MedMij:V1.0 AddendaInhoudelijkeGegevens: verschil tussen versies
Regel 6: | Regel 6: | ||
==Patiënt J. XXX_Amaya== | ==Patiënt J. XXX_Amaya== | ||
<section begin=XXX_Amaya /> | <section begin=XXX_Amaya /> | ||
− | + | {| class="wikitable" width="85%" | |
− | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patient | |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
|style="background-color: white;"|J. XXX_Amaya | |style="background-color: white;"|J. XXX_Amaya | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
|style="background-color: white;"|999911764 [BSN] | |style="background-color: white;"|999911764 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
|style="background-color: white;"|51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geboortedatum |
|style="background-color: white;"|6 aug 1964 | |style="background-color: white;"|6 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geslacht |
|style="background-color: white;"|Man (code = 'M') | |style="background-color: white;"|Man (code = 'M') | ||
|}<section end=XXX_Amaya /> | |}<section end=XXX_Amaya /> | ||
Regel 31: | Regel 31: | ||
<section begin=MA_XXX_Amaya /> | <section begin=MA_XXX_Amaya /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_1_MA_1 | |style="background-color: white;"|MBH_513_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|2 sep 2018, om 11:25 | |style="background-color: white;"|2 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 2 sep 2018, gedurende 60 dagen | |style="background-color: white;"|Vanaf 2 sep 2018, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geannuleerd indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 2 sep 2018, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 2 sep 2018, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|10 maal per dag 1 stuk | |style="background-color: white;"|10 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_1 | |style="background-color: white;"|MBH_513_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_1_MA_2 | |style="background-color: white;"|MBH_513_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 09:00 | |style="background-color: white;"|3 sep 2018, om 09:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_1 | |style="background-color: white;"|MBH_513_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_2_MA_2 | |style="background-color: white;"|MBH_513_2_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 14:32 | |style="background-color: white;"|3 sep 2018, om 14:32 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar afspraak of gebruik: TA |
|style="background-color: white;"|MBH_513_2_TA_1 | |style="background-color: white;"|MBH_513_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Opname (code = '305335007') | |style="background-color: white;"|Opname (code = '305335007') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Furosemide tablet 40mg | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toelichting |
|style="background-color: white;"|Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | |style="background-color: white;"|Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_3_MA_1 | |style="background-color: white;"|MBH_513_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 14:32 | |style="background-color: white;"|3 sep 2018, om 14:32 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 28 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar afspraak of gebruik: MGB |
|style="background-color: white;"|MBH_513_3_MGB_1 | |style="background-color: white;"|MBH_513_3_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Opname (code = '305335007') | |style="background-color: white;"|Opname (code = '305335007') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden van voorschrijven |
|style="background-color: white;"|Andere maligniteit bloed/lymfestelsel (code = 'B74') | |style="background-color: white;"|Andere maligniteit bloed/lymfestelsel (code = 'B74') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per week 5 stuks | |style="background-color: white;"|1 maal per week 5 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_3 | |style="background-color: white;"|MBH_513_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_4_MA_1 | |style="background-color: white;"|MBH_513_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|29 aug 2018, om 09:35 | |style="background-color: white;"|29 aug 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen | |style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag 1 stuk | |style="background-color: white;"|3 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Lichaamslengte |
|style="background-color: white;"|155 cm | |style="background-color: white;"|155 cm | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Lichaamsgewicht |
|style="background-color: white;"|54 kg | |style="background-color: white;"|54 kg | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aanvullende informatie |
|style="background-color: white;"|Bewust hoge dosering (code = '1') | |style="background-color: white;"|Bewust hoge dosering (code = '1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toelichting |
|style="background-color: white;"|In overleg met specialist | |style="background-color: white;"|In overleg met specialist | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_4 | |style="background-color: white;"|MBH_513_4 | ||
|}<section end=MA_XXX_Amaya /> | |}<section end=MA_XXX_Amaya /> | ||
Regel 265: | Regel 265: | ||
<section begin=VV_XXX_Amaya /> | <section begin=VV_XXX_Amaya /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_2_VV_2 | |style="background-color: white;"|MBH_513_2_VV_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|16 aug 2018, om 14:32 | |style="background-color: white;"|16 aug 2018, om 14:32 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd | |style="background-color: white;"|Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Te verstrekken hoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Furosemide tablet 40mg | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toelichting |
|style="background-color: white;"|Nog in te vullen, zie word... | |style="background-color: white;"|Nog in te vullen, zie word... | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_513_2_MA_2 | |style="background-color: white;"|MBH_513_2_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_4_VV_1 | |style="background-color: white;"|MBH_513_4_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|11 aug 2018, om 09:35 | |style="background-color: white;"|11 aug 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Te verstrekken hoeveelheid |
|style="background-color: white;"|40 stuks | |style="background-color: white;"|40 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afleverlocatie |
|style="background-color: white;"|Huisadres patiënt | |style="background-color: white;"|Huisadres patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aanvullende wensen |
|style="background-color: white;"|Bezorgen (code = '3') | |style="background-color: white;"|Bezorgen (code = '3') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_513_4_MA_1 | |style="background-color: white;"|MBH_513_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_4 | |style="background-color: white;"|MBH_513_4 | ||
|}<section end=VV_XXX_Amaya /> | |}<section end=VV_XXX_Amaya /> | ||
Regel 338: | Regel 338: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_1_TA_1 | |style="background-color: white;"|MBH_513_1_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 12:25 | |style="background-color: white;"|3 sep 2018, om 12:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geannuleerd indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_513_1_MA_2 | |style="background-color: white;"|MBH_513_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_1 | |style="background-color: white;"|MBH_513_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_2_TA_1 | |style="background-color: white;"|MBH_513_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|27 aug 2018, om 14:52 | |style="background-color: white;"|27 aug 2018, om 14:52 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 27 aug 2018, tot nader order | |style="background-color: white;"|Vanaf 27 aug 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Opname | |style="background-color: white;"|Opname | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG | + | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 27 aug 2018, tot nader order, 1 maal daags 1 stuk, oraal | |style="background-color: white;"|Vanaf 27 aug 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_513_2_MA_1 | |style="background-color: white;"|MBH_513_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_4_TA_1 | |style="background-color: white;"|MBH_513_4_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|29 aug 2018, om 09:45 | |style="background-color: white;"|29 aug 2018, om 09:45 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen | |style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG | + | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag 1 stuk | |style="background-color: white;"|3 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aanvullende informatie |
|style="background-color: white;"|Gebruiksinstructie gegeven (code = '10') | |style="background-color: white;"|Gebruiksinstructie gegeven (code = '10') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toelichting |
|style="background-color: white;"|Wegens niet leverbaar zijn van Broxil | |style="background-color: white;"|Wegens niet leverbaar zijn van Broxil | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_513_4_MA_1 | |style="background-color: white;"|MBH_513_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_4 | |style="background-color: white;"|MBH_513_4 | ||
|} | |} | ||
Regel 475: | Regel 475: | ||
<section begin=MVE_XXX_Amaya /> | <section begin=MVE_XXX_Amaya /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_2_MVE_1 | |style="background-color: white;"|MBH_513_2_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aanschrijfdatum |
|style="background-color: white;"|3 sep 2018, om 14:32 | |style="background-color: white;"|3 sep 2018, om 14:32 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekte hoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG | + | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_513_2_VV_2 | |style="background-color: white;"|MBH_513_2_VV_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_4_MVE_1 | |style="background-color: white;"|MBH_513_4_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|29 aug 2018, om 09:45 | |style="background-color: white;"|29 aug 2018, om 09:45 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekte hoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG | + | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afleverlocatie |
|style="background-color: white;"|Huisadres patiënt | |style="background-color: white;"|Huisadres patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aanvullende informatie |
|style="background-color: white;"|Aantal bewust gewijzigd (code = '1') | |style="background-color: white;"|Aantal bewust gewijzigd (code = '1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toelichting |
|style="background-color: white;"|Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. | |style="background-color: white;"|Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_513_4_VV_1 | |style="background-color: white;"|MBH_513_4_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_4 | |style="background-color: white;"|MBH_513_4 | ||
|}<section end=MVE_XXX_Amaya /> | |}<section end=MVE_XXX_Amaya /> | ||
Regel 542: | Regel 542: | ||
<section begin=MGB_XXX_Amaya /> | <section begin=MGB_XXX_Amaya /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_2_MGB_1 | |style="background-color: white;"|MBH_513_2_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|1 sep 2018, om 15:39 | |style="background-color: white;"|1 sep 2018, om 15:39 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 1 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 1 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Furosemide tablet 40mg | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 1 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | |style="background-color: white;"|Vanaf 1 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_513_2_MA_1 | |style="background-color: white;"|MBH_513_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_2_MGB_2 | |style="background-color: white;"|MBH_513_2_MGB_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 sep 2018, om 20:40 | |style="background-color: white;"|3 sep 2018, om 20:40 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 2 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 2 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Furosemide tablet 40mg | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 2 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | |style="background-color: white;"|Vanaf 2 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_513_2_MA_1 | |style="background-color: white;"|MBH_513_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Informant |
|style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger. | |style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_2_MGB_3 | |style="background-color: white;"|MBH_513_2_MGB_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 sep 2018, om 21:39 | |style="background-color: white;"|3 sep 2018, om 21:39 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Furosemide tablet 40mg | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_513_2_MA_1 | |style="background-color: white;"|MBH_513_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Informant |
|style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_5132_2_MGB_2 | |style="background-color: white;"|MBH_5132_2_MGB_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|16 aug 2018, om 20:59 | |style="background-color: white;"|16 aug 2018, om 20:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 16 aug 2018, gedurende 1 dag | |style="background-color: white;"|Vanaf 16 aug 2018, gedurende 1 dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|TEMAZEPAM APOTEX TABLET 10MG | + | |style="background-color: white;"|TEMAZEPAM APOTEX TABLET 10MG (code = '13806769') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf T, gedurende 1 dag, 1 maal daags 1 stuk, oraal | |style="background-color: white;"|Vanaf T, gedurende 1 dag, 1 maal daags 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde verstrekking |
|style="background-color: white;"|MBH_5132_2_MVE_1 | |style="background-color: white;"|MBH_5132_2_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_5132_2 | |style="background-color: white;"|MBH_5132_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_3_MGB_1 | |style="background-color: white;"|MBH_513_3_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|31 aug 2018, om 20:59 | |style="background-color: white;"|31 aug 2018, om 20:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 26 aug 2018, tot en met 31 aug 2018 23:59 | |style="background-color: white;"|Vanaf 26 aug 2018, tot en met 31 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 26 aug 2018 tot en met 31 aug 2018, 1 maal per week 5 stuks, oraal | |style="background-color: white;"|Vanaf 26 aug 2018 tot en met 31 aug 2018, 1 maal per week 5 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per week 5 stuks | |style="background-color: white;"|1 maal per week 5 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_513_3_MA_1 | |style="background-color: white;"|MBH_513_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden gebruik |
|style="background-color: white;"|Lymfekanker | |style="background-color: white;"|Lymfekanker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_3 | |style="background-color: white;"|MBH_513_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_513_4_MGB_1 | |style="background-color: white;"|MBH_513_4_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|30 aug 2018, om 22:35 | |style="background-color: white;"|30 aug 2018, om 22:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|False | |style="background-color: white;"|False | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 29 aug 2018, tot en met 30 aug 2018 23:59 | |style="background-color: white;"|Vanaf 29 aug 2018, tot en met 30 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|AMOXICILLINE CAPSULE 250MG | + | |style="background-color: white;"|AMOXICILLINE CAPSULE 250MG (code = '20044') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 29 aug 2018 tot en met 30 aug 2018, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 29 aug 2018 tot en met 30 aug 2018, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_513_4_MA_1 | |style="background-color: white;"|MBH_513_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_513_4 | |style="background-color: white;"|MBH_513_4 | ||
|}<section end=MGB_XXX_Amaya /> | |}<section end=MGB_XXX_Amaya /> | ||
==Patiënt Pauline P. XXX_Bourgonje== | ==Patiënt Pauline P. XXX_Bourgonje== | ||
<section begin=XXX_Bourgonje /> | <section begin=XXX_Bourgonje /> | ||
− | + | {| class="wikitable" width="85%" | |
− | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patient | |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
|style="background-color: white;"|Pauline P. XXX_Bourgonje | |style="background-color: white;"|Pauline P. XXX_Bourgonje | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
|style="background-color: white;"|999911296 [BSN] | |style="background-color: white;"|999911296 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
|style="background-color: white;"|12102 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|12102 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geboortedatum |
|style="background-color: white;"|1 aug 1964 | |style="background-color: white;"|1 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geslacht |
|style="background-color: white;"|Vrouw (code = 'F') | |style="background-color: white;"|Vrouw (code = 'F') | ||
|}<section end=XXX_Bourgonje /> | |}<section end=XXX_Bourgonje /> | ||
Regel 850: | Regel 850: | ||
<section begin=MA_XXX_Bourgonje /> | <section begin=MA_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_123_1_MA_1 | |style="background-color: white;"|MBH_123_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|27 aug 2018, om | |style="background-color: white;"|27 aug 2018, om | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 27 aug 2018, tot nader order | |style="background-color: white;"|Vanaf 27 aug 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 27 aug 2018, Zo nodig 2 maal daags aanbrengen, op de huid | |style="background-color: white;"|Vanaf 27 aug 2018, Zo nodig 2 maal daags aanbrengen, op de huid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Cutaan (code = '53') | |style="background-color: white;"|Cutaan (code = '53') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Zo nodig 2 maal per dag | |style="background-color: white;"|Zo nodig 2 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_123_1 | |style="background-color: white;"|MBH_123_1 | ||
|}<section end=MA_XXX_Bourgonje /> | |}<section end=MA_XXX_Bourgonje /> | ||
Regel 896: | Regel 896: | ||
<section begin=VV_XXX_Bourgonje /> | <section begin=VV_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_123_1_VV_1 | |style="background-color: white;"|MBH_123_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|27 aug 2018, om | |style="background-color: white;"|27 aug 2018, om | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Te verstrekken hoeveelheid |
|style="background-color: white;"|100 gram | |style="background-color: white;"|100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_123_1_MA_1 | |style="background-color: white;"|MBH_123_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_123_1 | |style="background-color: white;"|MBH_123_1 | ||
|}<section end=VV_XXX_Bourgonje /> | |}<section end=VV_XXX_Bourgonje /> | ||
Regel 929: | Regel 929: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_123_1_TA_1 | |style="background-color: white;"|MBH_123_1_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|27 aug 2018, om 00:00 | |style="background-color: white;"|27 aug 2018, om 00:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 27 aug 2018, tot nader order | |style="background-color: white;"|Vanaf 27 aug 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON | + | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 27 aug 2018, Zo nodig 2 maal daags aanbrengen, op de huid | |style="background-color: white;"|Vanaf 27 aug 2018, Zo nodig 2 maal daags aanbrengen, op de huid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Cutaan (code = '53') | |style="background-color: white;"|Cutaan (code = '53') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Zo nodig 2 maal per dag | |style="background-color: white;"|Zo nodig 2 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_123_1_MA_1 | |style="background-color: white;"|MBH_123_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_123_1 | |style="background-color: white;"|MBH_123_1 | ||
|} | |} | ||
Regel 975: | Regel 975: | ||
<section begin=MVE_XXX_Bourgonje /> | <section begin=MVE_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_123_1_MVE_1 | |style="background-color: white;"|MBH_123_1_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|27 aug 2018, om | |style="background-color: white;"|27 aug 2018, om | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekte hoeveelheid |
|style="background-color: white;"|100 gram | |style="background-color: white;"|100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON | + | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_123_1_VV_1 | |style="background-color: white;"|MBH_123_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_123_1 | |style="background-color: white;"|MBH_123_1 | ||
|}<section end=MVE_XXX_Bourgonje /> | |}<section end=MVE_XXX_Bourgonje /> | ||
Regel 1.005: | Regel 1.005: | ||
<section begin=MGB_XXX_Bourgonje /> | <section begin=MGB_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_123_1_MGB_1 | |style="background-color: white;"|MBH_123_1_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|12 aug 2018, om 20:58 | |style="background-color: white;"|12 aug 2018, om 20:58 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 11 aug 2018, gedurende 2 dagen | |style="background-color: white;"|Vanaf 11 aug 2018, gedurende 2 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag | |style="background-color: white;"|2 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_123_1_MA_1 | |style="background-color: white;"|MBH_123_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_123_1 | |style="background-color: white;"|MBH_123_1 | ||
|}<section end=MGB_XXX_Bourgonje /> | |}<section end=MGB_XXX_Bourgonje /> | ||
==Patiënt J. XXX_Cnossen== | ==Patiënt J. XXX_Cnossen== | ||
<section begin=XXX_Cnossen /> | <section begin=XXX_Cnossen /> | ||
− | + | {| class="wikitable" width="85%" | |
− | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patient | |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
|style="background-color: white;"|J. XXX_Cnossen | |style="background-color: white;"|J. XXX_Cnossen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
|style="background-color: white;"|999911740 [BSN] | |style="background-color: white;"|999911740 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
|style="background-color: white;"|31105 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|31105 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geboortedatum |
|style="background-color: white;"|4 aug 1964 | |style="background-color: white;"|4 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geslacht |
|style="background-color: white;"|Man (code = 'M') | |style="background-color: white;"|Man (code = 'M') | ||
|}<section end=XXX_Cnossen /> | |}<section end=XXX_Cnossen /> | ||
Regel 1.075: | Regel 1.075: | ||
<section begin=MA_XXX_Cnossen /> | <section begin=MA_XXX_Cnossen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_1_MA_1 | |style="background-color: white;"|MBH_313_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|26 mei 2018, om 12:11 | |style="background-color: white;"|26 mei 2018, om 12:11 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 26 mei 2018, tot nader order | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug | + | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Inhalatie (code = '62') | |style="background-color: white;"|Inhalatie (code = '62') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_1_MA_2 | |style="background-color: white;"|MBH_313_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|5 jul 2018, om 13:54 | |style="background-color: white;"|5 jul 2018, om 13:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 26 mei 2018, tot en met 6 jul 2018 23:59 | |style="background-color: white;"|Vanaf 26 mei 2018, tot en met 6 jul 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Indicatie vervallen (code = '9') | |style="background-color: white;"|Indicatie vervallen (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug | + | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 26 mei 2018 tot en met 6 jul 2018, 1 maal per dag 1 dosis, inhalatie | |style="background-color: white;"|Vanaf 26 mei 2018 tot en met 6 jul 2018, 1 maal per dag 1 dosis, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Inhalatie (code = '62') | |style="background-color: white;"|Inhalatie (code = '62') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_2_MA_1 | |style="background-color: white;"|MBH_313_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|21 apr 2017, om 10:19 | |style="background-color: white;"|21 apr 2017, om 10:19 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 21 apr 2017, tot nader order | |style="background-color: white;"|Vanaf 21 apr 2017, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml | + | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 21 apr 2017, tot nader order, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf 21 apr 2017, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oculair (code = '7') | |style="background-color: white;"|Oculair (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|In beide ogen (code = '1026') | |style="background-color: white;"|In beide ogen (code = '1026') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_2_MA_2 | |style="background-color: white;"|MBH_313_2_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|2 sep 2017, om 17:54 | |style="background-color: white;"|2 sep 2017, om 17:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 21 apr 2017, tot en met 2 sep 2017 17:00 | |style="background-color: white;"|Vanaf 21 apr 2017, tot en met 2 sep 2017 17:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Indicatie vervallen (code = '9') | |style="background-color: white;"|Indicatie vervallen (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml | + | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 21 apr 2017 tot en met 2 sep 2017 17:00, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf 21 apr 2017 tot en met 2 sep 2017 17:00, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oculair (code = '7') | |style="background-color: white;"|Oculair (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|In beide ogen (code = '1026') | |style="background-color: white;"|In beide ogen (code = '1026') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_3_MA_1 | |style="background-color: white;"|MBH_313_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|26 mei 2018, om 12:11 | |style="background-color: white;"|26 mei 2018, om 12:11 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 26 mei 2018, tot nader order | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO | + | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_3_MA_2 | |style="background-color: white;"|MBH_313_3_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|30 aug 2018, om 13:54 | |style="background-color: white;"|30 aug 2018, om 13:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 26 mei 2018, tot en met 29 aug 2018 23:59 | |style="background-color: white;"|Vanaf 26 mei 2018, tot en met 29 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Onderbreking | |style="background-color: white;"|Onderbreking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO | + | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 26 mei 2018 tot en met 29 aug 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | |style="background-color: white;"|Vanaf 26 mei 2018 tot en met 29 aug 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_4_MA_1 | |style="background-color: white;"|MBH_313_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|7 nov 2017, om 14:23 | |style="background-color: white;"|7 nov 2017, om 14:23 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 7 nov 2017, tot nader order | |style="background-color: white;"|Vanaf 7 nov 2017, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Omeprazol tablet MSR 40mg | + | |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 7 nov 2017, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 7 nov 2017, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_4_MA_2 | |style="background-color: white;"|MBH_313_4_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|24 jan 2018, om 08:54 | |style="background-color: white;"|24 jan 2018, om 08:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 7 nov 2017, tot en met 23 jan 2018 23:59 | |style="background-color: white;"|Vanaf 7 nov 2017, tot en met 23 jan 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Onderbreking | |style="background-color: white;"|Onderbreking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Omeprazol tablet MSR 40mg | + | |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 7 nov 2017 tot en met 23 jan 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | |style="background-color: white;"|Vanaf 7 nov 2017 tot en met 23 jan 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|}<section end=MA_XXX_Cnossen /> | |}<section end=MA_XXX_Cnossen /> | ||
Regel 1.417: | Regel 1.417: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_1_TA_1 | |style="background-color: white;"|MBH_313_1_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|26 mei 2018, om 12:11 | |style="background-color: white;"|26 mei 2018, om 12:11 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 26 mei 2018, tot nader order | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|SPIRIVA INHALPDR 18MCG | + | |style="background-color: white;"|SPIRIVA INHALPDR 18MCG (code = '1476866') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Inhalatie (code = '62') | |style="background-color: white;"|Inhalatie (code = '62') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_313_1_MA_1 | |style="background-color: white;"|MBH_313_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_1_TA_2 | |style="background-color: white;"|MBH_313_1_TA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|5 jul 2018, om 13:54 | |style="background-color: white;"|5 jul 2018, om 13:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 26 mei 2018, tot en met 6 jul 2018 23:59 | |style="background-color: white;"|Vanaf 26 mei 2018, tot en met 6 jul 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|SPIRIVA INHALPDR 18MCG | + | |style="background-color: white;"|SPIRIVA INHALPDR 18MCG (code = '1476866') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 26 mei 2018 tot en met 6 jul 2018, 1 maal per dag 1 dosis, inhalatie | |style="background-color: white;"|Vanaf 26 mei 2018 tot en met 6 jul 2018, 1 maal per dag 1 dosis, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Inhalatie (code = '62') | |style="background-color: white;"|Inhalatie (code = '62') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_313_1_MA_2 | |style="background-color: white;"|MBH_313_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_2_TA_1 | |style="background-color: white;"|MBH_313_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|21 apr 2017, om 10:19 | |style="background-color: white;"|21 apr 2017, om 10:19 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 21 apr 2017, tot nader order | |style="background-color: white;"|Vanaf 21 apr 2017, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML | + | |style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 21 apr 2017, tot nader order, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf 21 apr 2017, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oculair (code = '7') | |style="background-color: white;"|Oculair (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|In beide ogen (code = '1026') | |style="background-color: white;"|In beide ogen (code = '1026') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_313_2_MA_1 | |style="background-color: white;"|MBH_313_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_2_TA_2 | |style="background-color: white;"|MBH_313_2_TA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|2 sep 2017, om 17:54 | |style="background-color: white;"|2 sep 2017, om 17:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 21 apr 2017, tot en met 2 sep 2017 17:00 | |style="background-color: white;"|Vanaf 21 apr 2017, tot en met 2 sep 2017 17:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML | + | |style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 21 apr 2017 tot en met 2 sep 2017 17:00, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf 21 apr 2017 tot en met 2 sep 2017 17:00, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oculair (code = '7') | |style="background-color: white;"|Oculair (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|In beide ogen (code = '1026') | |style="background-color: white;"|In beide ogen (code = '1026') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_313_2_MA_2 | |style="background-color: white;"|MBH_313_2_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_3_TA_1 | |style="background-color: white;"|MBH_313_3_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|26 mei 2018, om 12:30 | |style="background-color: white;"|26 mei 2018, om 12:30 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 26 mei 2018, tot nader order | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG | + | |style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_313_3_MA_1 | |style="background-color: white;"|MBH_313_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_3_TA_2 | |style="background-color: white;"|MBH_313_3_TA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|30 aug 2018, om 14:54 | |style="background-color: white;"|30 aug 2018, om 14:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 26 mei 2018, tot en met 29 aug 2018 23:59 | |style="background-color: white;"|Vanaf 26 mei 2018, tot en met 29 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Onderbreking | |style="background-color: white;"|Onderbreking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG | + | |style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 26 mei 2018 tot en met 29 aug 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | |style="background-color: white;"|Vanaf 26 mei 2018 tot en met 29 aug 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_313_3_MA_2 | |style="background-color: white;"|MBH_313_3_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_4_TA_1 | |style="background-color: white;"|MBH_313_4_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|7 nov 2017, om 15:23 | |style="background-color: white;"|7 nov 2017, om 15:23 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 7 nov 2017, tot nader order | |style="background-color: white;"|Vanaf 7 nov 2017, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG | + | |style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 7 nov 2017, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 7 nov 2017, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_313_4_MA_1 | |style="background-color: white;"|MBH_313_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_4_TA_2 | |style="background-color: white;"|MBH_313_4_TA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|24 jan 2018, om 09:54 | |style="background-color: white;"|24 jan 2018, om 09:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 7 nov 2017, tot en met 23 jan 2018 23:59 | |style="background-color: white;"|Vanaf 7 nov 2017, tot en met 23 jan 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Onderbreking | |style="background-color: white;"|Onderbreking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG | + | |style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 7 nov 2017 tot en met 23 jan 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | |style="background-color: white;"|Vanaf 7 nov 2017 tot en met 23 jan 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_313_4_MA_2 | |style="background-color: white;"|MBH_313_4_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|} | |} | ||
Regel 1.765: | Regel 1.765: | ||
<section begin=MGB_XXX_Cnossen /> | <section begin=MGB_XXX_Cnossen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_1_MGB_1 | |style="background-color: white;"|MBH_313_1_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|6 jul 2018, om 12:11 | |style="background-color: white;"|6 jul 2018, om 12:11 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 6 jul 2018, tot nader order | |style="background-color: white;"|Vanaf 6 jul 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug | + | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf T-100, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | |style="background-color: white;"|Vanaf T-100, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Inhalatie (code = '62') | |style="background-color: white;"|Inhalatie (code = '62') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_313_1_MA_1 | |style="background-color: white;"|MBH_313_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_1_MGB_2 | |style="background-color: white;"|MBH_313_1_MGB_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|18 jun 2018, om 15:25 | |style="background-color: white;"|18 jun 2018, om 15:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|False | |style="background-color: white;"|False | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 8 mei 2018, tot en met 18 jun 2018 23:59 | |style="background-color: white;"|Vanaf 8 mei 2018, tot en met 18 jun 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug | + | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf T-100, tot en met T-59, 1 maal per dag 1 dosis, inhalatie | |style="background-color: white;"|Vanaf T-100, tot en met T-59, 1 maal per dag 1 dosis, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Inhalatie (code = '62') | |style="background-color: white;"|Inhalatie (code = '62') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_313_1_MA_2 | |style="background-color: white;"|MBH_313_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_2_MGB_1 | |style="background-color: white;"|MBH_313_2_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 apr 2017, om 10:19 | |style="background-color: white;"|3 apr 2017, om 10:19 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 apr 2017, tot nader order | |style="background-color: white;"|Vanaf 3 apr 2017, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml | + | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf T-500, tot nader order, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf T-500, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oculair (code = '7') | |style="background-color: white;"|Oculair (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|In beide ogen (code = '1026') | |style="background-color: white;"|In beide ogen (code = '1026') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_313_2_MA_1 | |style="background-color: white;"|MBH_313_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_2_MGB_2 | |style="background-color: white;"|MBH_313_2_MGB_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|15 aug 2017, om 17:54 | |style="background-color: white;"|15 aug 2017, om 17:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 apr 2017, tot en met 15 aug 2017 17:00 | |style="background-color: white;"|Vanaf 3 apr 2017, tot en met 15 aug 2017 17:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml | + | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf T-500, tot en met T-366 17:00, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf T-500, tot en met T-366 17:00, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oculair (code = '7') | |style="background-color: white;"|Oculair (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|In beide ogen (code = '1026') | |style="background-color: white;"|In beide ogen (code = '1026') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_313_2_MA_2 | |style="background-color: white;"|MBH_313_2_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_3_MGB_1 | |style="background-color: white;"|MBH_313_3_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|8 mei 2018, om 12:11 | |style="background-color: white;"|8 mei 2018, om 12:11 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 8 mei 2018, tot nader order | |style="background-color: white;"|Vanaf 8 mei 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO | + | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf T-100, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T-100, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_313_3_MA_1 | |style="background-color: white;"|MBH_313_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_3_MGB_2 | |style="background-color: white;"|MBH_313_3_MGB_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|12 aug 2017, om 13:54 | |style="background-color: white;"|12 aug 2017, om 13:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 8 mei 2018, tot en met 11 aug 2018 23:59 | |style="background-color: white;"|Vanaf 8 mei 2018, tot en met 11 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Onderbreking | |style="background-color: white;"|Onderbreking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO | + | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf T-100, tot en met T-5, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-4 | |style="background-color: white;"|Vanaf T-100, tot en met T-5, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-4 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_313_3_MA_2 | |style="background-color: white;"|MBH_313_3_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_4_MGB_1 | |style="background-color: white;"|MBH_313_4_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|20 okt 2017, om 14:23 | |style="background-color: white;"|20 okt 2017, om 14:23 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 20 okt 2017, tot nader order | |style="background-color: white;"|Vanaf 20 okt 2017, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Omeprazol tablet MSR 40mg | + | |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf T-300, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T-300, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_313_4_MA_1 | |style="background-color: white;"|MBH_313_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_313_4_MGB_2 | |style="background-color: white;"|MBH_313_4_MGB_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|6 jan 2018, om 08:54 | |style="background-color: white;"|6 jan 2018, om 08:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 20 okt 2017, tot en met 5 jan 2018 23:59 | |style="background-color: white;"|Vanaf 20 okt 2017, tot en met 5 jan 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Onderbreking | |style="background-color: white;"|Onderbreking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Omeprazol tablet MSR 40mg | + | |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf T-300, tot en met T-223, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-222 | |style="background-color: white;"|Vanaf T-300, tot en met T-223, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-222 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_313_4_MA_2 | |style="background-color: white;"|MBH_313_4_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|}<section end=MGB_XXX_Cnossen /> | |}<section end=MGB_XXX_Cnossen /> | ||
==Patiënt R. XXX_Dirksz== | ==Patiënt R. XXX_Dirksz== | ||
<section begin=XXX_Dirksz /> | <section begin=XXX_Dirksz /> | ||
− | + | {| class="wikitable" width="85%" | |
− | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patient | |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
|style="background-color: white;"|R. XXX_Dirksz | |style="background-color: white;"|R. XXX_Dirksz | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
|style="background-color: white;"|999911326 [BSN] | |style="background-color: white;"|999911326 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
|style="background-color: white;"|11101 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|11101 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geboortedatum |
|style="background-color: white;"|1 aug 1964 | |style="background-color: white;"|1 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geslacht |
|style="background-color: white;"|Man (code = 'M') | |style="background-color: white;"|Man (code = 'M') | ||
|}<section end=XXX_Dirksz /> | |}<section end=XXX_Dirksz /> | ||
Regel 2.185: | Regel 2.185: | ||
<section begin=MA_XXX_Dirksz /> | <section begin=MA_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_113_1_MA_1 | |style="background-color: white;"|MBH_113_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|15 jul 2018, om 11:25 | |style="background-color: white;"|15 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Metoclopramide zetpil 20mg | + | |style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Rectaal (code = '12') | |style="background-color: white;"|Rectaal (code = '12') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_113_1 | |style="background-color: white;"|MBH_113_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_113_2_MA_1 | |style="background-color: white;"|MBH_113_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|4 aug 2018, om 14:55 | |style="background-color: white;"|4 aug 2018, om 14:55 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Zestril tabel 10mg | + | |style="background-color: white;"|Zestril tabel 10mg (code = '615560') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_113_2 | |style="background-color: white;"|MBH_113_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_113_3_MA_1 | |style="background-color: white;"|MBH_113_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|4 aug 2018, om 14:57 | |style="background-color: white;"|4 aug 2018, om 14:57 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 4 aug 2018, tot nader order | |style="background-color: white;"|Vanaf 4 aug 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 4 aug 2018, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 4 aug 2018, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_113_3 | |style="background-color: white;"|MBH_113_3 | ||
|}<section end=MA_XXX_Dirksz /> | |}<section end=MA_XXX_Dirksz /> | ||
Regel 2.310: | Regel 2.310: | ||
<section begin=VV_XXX_Dirksz /> | <section begin=VV_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_113_1_VV_1 | |style="background-color: white;"|MBH_113_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|15 jul 2018, om 11:25 | |style="background-color: white;"|15 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Te verstrekken hoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Metoclopramide zetpil 20mg | + | |style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_113_1_MA_1 | |style="background-color: white;"|MBH_113_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_113_1 | |style="background-color: white;"|MBH_113_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_113_2_VV_1 | |style="background-color: white;"|MBH_113_2_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|4 aug 2018, om 14:55 | |style="background-color: white;"|4 aug 2018, om 14:55 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Te verstrekken hoeveelheid |
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Zestril tabel 10mg | + | |style="background-color: white;"|Zestril tabel 10mg (code = '615560') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_113_2_MA_1 | |style="background-color: white;"|MBH_113_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_113_2 | |style="background-color: white;"|MBH_113_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_113_3_VV_1 | |style="background-color: white;"|MBH_113_3_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|4 aug 2018, om 14:57 | |style="background-color: white;"|4 aug 2018, om 14:57 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Te verstrekken hoeveelheid |
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_113_3_MA_1 | |style="background-color: white;"|MBH_113_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_113_3 | |style="background-color: white;"|MBH_113_3 | ||
|}<section end=VV_XXX_Dirksz /> | |}<section end=VV_XXX_Dirksz /> | ||
Regel 2.405: | Regel 2.405: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_113_1_TA_1 | |style="background-color: white;"|MBH_113_1_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|15 jul 2018, om 11:25 | |style="background-color: white;"|15 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|PRIMPERAN ZETPIL 20MG | + | |style="background-color: white;"|PRIMPERAN ZETPIL 20MG (code = '229709') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Rectaal (code = '12') | |style="background-color: white;"|Rectaal (code = '12') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_113_1_MA_1 | |style="background-color: white;"|MBH_113_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_113_1 | |style="background-color: white;"|MBH_113_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_113_2_TA_1 | |style="background-color: white;"|MBH_113_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|4 aug 2018, om 14:55 | |style="background-color: white;"|4 aug 2018, om 14:55 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Zestril tabel 10mg | + | |style="background-color: white;"|Zestril tabel 10mg (code = '615560') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_113_2_MA_1 | |style="background-color: white;"|MBH_113_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_113_2 | |style="background-color: white;"|MBH_113_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_113_3_TA_1 | |style="background-color: white;"|MBH_113_3_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|4 aug 2018, om 14:57 | |style="background-color: white;"|4 aug 2018, om 14:57 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 4 aug 2018, tot nader order | |style="background-color: white;"|Vanaf 4 aug 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ROTER APC TABLET | + | |style="background-color: white;"|ROTER APC TABLET (code = '202185') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 4 aug 2018, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 4 aug 2018, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_113_2_MA_1 | |style="background-color: white;"|MBH_113_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_113_3 | |style="background-color: white;"|MBH_113_3 | ||
|} | |} | ||
Regel 2.530: | Regel 2.530: | ||
<section begin=MVE_XXX_Dirksz /> | <section begin=MVE_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_113_1_MVE_1 | |style="background-color: white;"|MBH_113_1_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|15 jul 2018, om 12:25 | |style="background-color: white;"|15 jul 2018, om 12:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekte hoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|PRIMPERAN ZETPIL 20MG | + | |style="background-color: white;"|PRIMPERAN ZETPIL 20MG (code = '229709') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_113_1_VV_1 | |style="background-color: white;"|MBH_113_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_113_1 | |style="background-color: white;"|MBH_113_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_113_2_MVE_1 | |style="background-color: white;"|MBH_113_2_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|4 aug 2018, om 15:55 | |style="background-color: white;"|4 aug 2018, om 15:55 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekte hoeveelheid |
|style="background-color: white;"|25 stuks | |style="background-color: white;"|25 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Zestril tablet 10mg | + | |style="background-color: white;"|Zestril tablet 10mg (code = '615560') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_113_2_VV_1 | |style="background-color: white;"|MBH_113_2_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_113_2 | |style="background-color: white;"|MBH_113_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_113_3_MVE_1 | |style="background-color: white;"|MBH_113_3_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|4 aug 2018, om 15:56 | |style="background-color: white;"|4 aug 2018, om 15:56 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekte hoeveelheid |
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ROTER APC TABLET | + | |style="background-color: white;"|ROTER APC TABLET (code = '202185') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_113_3_VV_1 | |style="background-color: white;"|MBH_113_3_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_113_3 | |style="background-color: white;"|MBH_113_3 | ||
|}<section end=MVE_XXX_Dirksz /> | |}<section end=MVE_XXX_Dirksz /> | ||
Regel 2.616: | Regel 2.616: | ||
<section begin=MGB_XXX_Dirksz /> | <section begin=MGB_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_113_1_MGB_1 | |style="background-color: white;"|MBH_113_1_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|17 jul 2018, om 11:25 | |style="background-color: white;"|17 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 17 jul 2018, gedurende 1 dag | |style="background-color: white;"|Vanaf 17 jul 2018, gedurende 1 dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Metoclopramide zetpil 20mg | + | |style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 17 jul 2018, gedurende 1 dag, 1 maal per dag 1 stuk, rectaal | |style="background-color: white;"|Vanaf 17 jul 2018, gedurende 1 dag, 1 maal per dag 1 stuk, rectaal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Rectaal (code = '12') | |style="background-color: white;"|Rectaal (code = '12') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_113_1_MA_1 | |style="background-color: white;"|MBH_113_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_113_1 | |style="background-color: white;"|MBH_113_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_113_2_MGB_1 | |style="background-color: white;"|MBH_113_2_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|21 aug 2018, om 14:55 | |style="background-color: white;"|21 aug 2018, om 14:55 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Zestril tabel 10mg | + | |style="background-color: white;"|Zestril tabel 10mg (code = '615560') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_113_2_MA_1 | |style="background-color: white;"|MBH_113_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_113_2 | |style="background-color: white;"|MBH_113_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_113_3_MGB_1 | |style="background-color: white;"|MBH_113_3_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|5 aug 2018, om 14:57 | |style="background-color: white;"|5 aug 2018, om 14:57 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 5 aug 2018, tot en met 26 aug 2018 23:59 | |style="background-color: white;"|Vanaf 5 aug 2018, tot en met 26 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 5 aug 2018 tot en met 26 aug 2018, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 5 aug 2018 tot en met 26 aug 2018, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_113_3_MA_1 | |style="background-color: white;"|MBH_113_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_113_3 | |style="background-color: white;"|MBH_113_3 | ||
|}<section end=MGB_XXX_Dirksz /> | |}<section end=MGB_XXX_Dirksz /> | ||
==Patiënt R. XXX_Gobee== | ==Patiënt R. XXX_Gobee== | ||
<section begin=XXX_Gobee /> | <section begin=XXX_Gobee /> | ||
− | + | {| class="wikitable" width="85%" | |
− | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patient | |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
|style="background-color: white;"|R. XXX_Gobee | |style="background-color: white;"|R. XXX_Gobee | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
|style="background-color: white;"|999911314 [BSN] | |style="background-color: white;"|999911314 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
|style="background-color: white;"|21104 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|21104 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geboortedatum |
|style="background-color: white;"|1 aug 1964 | |style="background-color: white;"|1 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geslacht |
|style="background-color: white;"|Vrouw (code = 'F') | |style="background-color: white;"|Vrouw (code = 'F') | ||
|}<section end=XXX_Gobee /> | |}<section end=XXX_Gobee /> | ||
Regel 2.786: | Regel 2.786: | ||
<section begin=MA_XXX_Gobee /> | <section begin=MA_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|15 jul 2018, om 11:25 | |style="background-color: white;"|15 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 15 jul 2018, tot nader order | |style="background-color: white;"|Vanaf 15 jul 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, 1 à 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, 1 à 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_MA_2 | |style="background-color: white;"|MBH_213_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|25 jul 2018, om 09:13 | |style="background-color: white;"|25 jul 2018, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 15 jul 2018, tot en met 24 jul 2018 23:59 | |style="background-color: white;"|Vanaf 15 jul 2018, tot en met 24 jul 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar afspraak of gebruik: MA |
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 15 jul 2018 tot en met 24 jul 2018, 1 à 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 15 jul 2018 tot en met 24 jul 2018, 1 à 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_MA_3 | |style="background-color: white;"|MBH_213_1_MA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|25 jul 2018, om 09:13 | |style="background-color: white;"|25 jul 2018, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar afspraak of gebruik: MA |
|style="background-color: white;"|MBH_213_1_MA_2 | |style="background-color: white;"|MBH_213_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Geen of onvoldoende effect (code = '5') | |style="background-color: white;"|Geen of onvoldoende effect (code = '5') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_MA_4 | |style="background-color: white;"|MBH_213_1_MA_4 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|19 aug 2018, om 09:13 | |style="background-color: white;"|19 aug 2018, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 25 jul 2018, tot en met 19 aug 2018 23:59 | |style="background-color: white;"|Vanaf 25 jul 2018, tot en met 19 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar afspraak of gebruik: MA |
|style="background-color: white;"|MBH_213_1_MA_3 | |style="background-color: white;"|MBH_213_1_MA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 25 jul 2018 tot en met 19 aug 2018, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 25 jul 2018 tot en met 19 aug 2018, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_MA_5 | |style="background-color: white;"|MBH_213_1_MA_5 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|20 aug 2018, om 16:25 | |style="background-color: white;"|20 aug 2018, om 16:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar afspraak of gebruik: MA |
|style="background-color: white;"|MBH_213_1_MA_4 | |style="background-color: white;"|MBH_213_1_MA_4 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Wens patiënt (code = '12') | |style="background-color: white;"|Wens patiënt (code = '12') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|}<section end=MA_XXX_Gobee /> | |}<section end=MA_XXX_Gobee /> | ||
Regel 3.005: | Regel 3.005: | ||
<section begin=VV_XXX_Gobee /> | <section begin=VV_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_VV_1 | |style="background-color: white;"|MBH_213_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|15 jul 2018, om 11:25 | |style="background-color: white;"|15 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Te verstrekken hoeveelheid |
|style="background-color: white;"|40 stuks | |style="background-color: white;"|40 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aantal herhalingen |
|style="background-color: white;"|1 | |style="background-color: white;"|1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_VV_2 | |style="background-color: white;"|MBH_213_1_VV_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|25 jul 2018, om 09:13 | |style="background-color: white;"|25 jul 2018, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Te verstrekken hoeveelheid |
|style="background-color: white;"|60 stuks | |style="background-color: white;"|60 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aantal herhalingen |
|style="background-color: white;"|1 | |style="background-color: white;"|1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_213_1_MA_3 | |style="background-color: white;"|MBH_213_1_MA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_VV_3 | |style="background-color: white;"|MBH_213_1_VV_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|19 aug 2018, om 16:25 | |style="background-color: white;"|19 aug 2018, om 16:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verbruiksperiode |
|style="background-color: white;"|Vanaf 1 aug 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 1 aug 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Beoogd verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_213_1_MA_5 | |style="background-color: white;"|MBH_213_1_MA_5 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|}<section end=VV_XXX_Gobee /> | |}<section end=VV_XXX_Gobee /> | ||
Regel 3.106: | Regel 3.106: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_TA_1 | |style="background-color: white;"|MBH_213_1_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|15 jul 2018, om 11:25 | |style="background-color: white;"|15 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 15 jul 2018, tot nader order | |style="background-color: white;"|Vanaf 15 jul 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, 1 à 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, 1 à 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_TA_2 | |style="background-color: white;"|MBH_213_1_TA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|25 jul 2018, om 09:13 | |style="background-color: white;"|25 jul 2018, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 15 jul 2018, tot en met 24 jul 2018 23:59 | |style="background-color: white;"|Vanaf 15 jul 2018, tot en met 24 jul 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 15 jul 2018 tot en met 24 jul 2018, 1 à 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 15 jul 2018 tot en met 24 jul 2018, 1 à 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_213_1_MA_2 | |style="background-color: white;"|MBH_213_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_TA_3 | |style="background-color: white;"|MBH_213_1_TA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|25 jul 2018, om 09:13 | |style="background-color: white;"|25 jul 2018, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_213_1_MA_3 | |style="background-color: white;"|MBH_213_1_MA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_TA_4 | |style="background-color: white;"|MBH_213_1_TA_4 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|19 aug 2018, om 09:13 | |style="background-color: white;"|19 aug 2018, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 25 jul 2018, tot en met 19 aug 2018 23:59 | |style="background-color: white;"|Vanaf 25 jul 2018, tot en met 19 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 25 jul 2018 tot en met 19 aug 2018, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 25 jul 2018 tot en met 19 aug 2018, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_213_1_MA_4 | |style="background-color: white;"|MBH_213_1_MA_4 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_TA_5 | |style="background-color: white;"|MBH_213_1_TA_5 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|19 aug 2018, om 16:25 | |style="background-color: white;"|19 aug 2018, om 16:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_213_1_MA_5 | |style="background-color: white;"|MBH_213_1_MA_5 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
Regel 3.319: | Regel 3.319: | ||
<section begin=MVE_XXX_Gobee /> | <section begin=MVE_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_MVE_1 | |style="background-color: white;"|MBH_213_1_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|15 jul 2018, om 13:25 | |style="background-color: white;"|15 jul 2018, om 13:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekte hoeveelheid |
|style="background-color: white;"|40 stuks | |style="background-color: white;"|40 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_213_1_VV_1 | |style="background-color: white;"|MBH_213_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_MVE_2 | |style="background-color: white;"|MBH_213_1_MVE_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|25 jul 2018, om 09:13 | |style="background-color: white;"|25 jul 2018, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekte hoeveelheid |
|style="background-color: white;"|60 stuks | |style="background-color: white;"|60 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_213_1_VV_2 | |style="background-color: white;"|MBH_213_1_VV_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_MVE_3 | |style="background-color: white;"|MBH_213_1_MVE_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|19 aug 2018, om 17:25 | |style="background-color: white;"|19 aug 2018, om 17:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekte hoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verbruiksduur |
|style="background-color: white;"|30 dagen | |style="background-color: white;"|30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar verstrekkingsverzoek |
|style="background-color: white;"|MBH_213_1_VV_2 | |style="background-color: white;"|MBH_213_1_VV_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|}<section end=MVE_XXX_Gobee /> | |}<section end=MVE_XXX_Gobee /> | ||
Regel 3.408: | Regel 3.408: | ||
<section begin=MGB_XXX_Gobee /> | <section begin=MGB_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_MGB_1 | |style="background-color: white;"|MBH_213_1_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|18 jul 2018, om 11:25 | |style="background-color: white;"|18 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 3 dagen | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 3 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 3 dagen, 1 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 3 dagen, 1 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_MGB_2 | |style="background-color: white;"|MBH_213_1_MGB_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|24 jul 2018, om 11:25 | |style="background-color: white;"|24 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 19 jul 2018, gedurende 6 dagen | |style="background-color: white;"|Vanaf 19 jul 2018, gedurende 6 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 19 jul 2018, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 19 jul 2018, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_MGB_3 | |style="background-color: white;"|MBH_213_1_MGB_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|30 jul 2018, om 19:25 | |style="background-color: white;"|30 jul 2018, om 19:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 25 jul 2018, gedurende 6 dagen | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 6 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 25 jul 2018, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: TA |
|style="background-color: white;"|MBH_213_1_TA_3 | |style="background-color: white;"|MBH_213_1_TA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_MGB_4 | |style="background-color: white;"|MBH_213_1_MGB_4 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|18 aug 2018, om 11:25 | |style="background-color: white;"|18 aug 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 31 jul 2018, gedurende 19 dagen | |style="background-color: white;"|Vanaf 31 jul 2018, gedurende 19 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 31 jul 2018, gedurende 19 dagen, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 31 jul 2018, gedurende 19 dagen, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_213_1_MA_3 | |style="background-color: white;"|MBH_213_1_MA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_213_1_MGB_5 | |style="background-color: white;"|MBH_213_1_MGB_5 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|24 aug 2018, om 11:25 | |style="background-color: white;"|24 aug 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 20 aug 2018, gedurende 5 dagen | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 5 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 20 aug 2018, gedurende 5 dagen, 1 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 5 dagen, 1 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_213_1_MA_5 | |style="background-color: white;"|MBH_213_1_MA_5 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|}<section end=MGB_XXX_Gobee /> | |}<section end=MGB_XXX_Gobee /> | ||
==Patiënt J. XXX_Kilkenny== | ==Patiënt J. XXX_Kilkenny== | ||
<section begin=XXX_Kilkenny /> | <section begin=XXX_Kilkenny /> | ||
− | + | {| class="wikitable" width="85%" | |
− | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patient | |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
|style="background-color: white;"|J. XXX_Kilkenny | |style="background-color: white;"|J. XXX_Kilkenny | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
|style="background-color: white;"|999911752 [BSN] | |style="background-color: white;"|999911752 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
|style="background-color: white;"|22108 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|22108 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geboortedatum |
|style="background-color: white;"|5 aug 1964 | |style="background-color: white;"|5 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geslacht |
|style="background-color: white;"|Vrouw (code = 'F') | |style="background-color: white;"|Vrouw (code = 'F') | ||
|}<section end=XXX_Kilkenny /> | |}<section end=XXX_Kilkenny /> | ||
Regel 3.666: | Regel 3.666: | ||
<section begin=MA_XXX_Kilkenny /> | <section begin=MA_XXX_Kilkenny /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_323_1_MA_1 | |style="background-color: white;"|MBH_323_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|29 aug 2018, om 15:34 | |style="background-color: white;"|29 aug 2018, om 15:34 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 14 aug 2018, tot en met 28 aug 2018 23:59 | |style="background-color: white;"|Vanaf 14 aug 2018, tot en met 28 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Stoptype |
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK | + | |style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 14 aug 2018 tot en met 28 aug 2018, 3x per dag 1 tablet | |style="background-color: white;"|Vanaf 14 aug 2018 tot en met 28 aug 2018, 3x per dag 1 tablet | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag 1 stuk | |style="background-color: white;"|3 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_323_1 | |style="background-color: white;"|MBH_323_1 | ||
|}<section end=MA_XXX_Kilkenny /> | |}<section end=MA_XXX_Kilkenny /> | ||
Regel 3.709: | Regel 3.709: | ||
<section begin=MGB_XXX_Kilkenny /> | <section begin=MGB_XXX_Kilkenny /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_323_1_MGB_1 | |style="background-color: white;"|MBH_323_1_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|24 aug 2018, om 11:25 | |style="background-color: white;"|24 aug 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 14 aug 2018, tot nader order | |style="background-color: white;"|Vanaf 14 aug 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK | + | |style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 14 aug 2018, 3x per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 14 aug 2018, 3x per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag 1 stuk | |style="background-color: white;"|3 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_323_1 | |style="background-color: white;"|MBH_323_1 | ||
|}<section end=MGB_XXX_Kilkenny /> | |}<section end=MGB_XXX_Kilkenny /> | ||
==Patiënt R. XXX_Ruys== | ==Patiënt R. XXX_Ruys== | ||
<section begin=XXX_Ruys /> | <section begin=XXX_Ruys /> | ||
− | + | {| class="wikitable" width="85%" | |
− | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patient | |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
|style="background-color: white;"|R. XXX_Ruys | |style="background-color: white;"|R. XXX_Ruys | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
|style="background-color: white;"|999911351 [BSN] | |style="background-color: white;"|999911351 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
|style="background-color: white;"|13103 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|13103 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geboortedatum |
|style="background-color: white;"|1 aug 1964 | |style="background-color: white;"|1 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geslacht |
|style="background-color: white;"|Man (code = 'M') | |style="background-color: white;"|Man (code = 'M') | ||
|}<section end=XXX_Ruys /> | |}<section end=XXX_Ruys /> | ||
==Patiënt R. XXX_Strengersz== | ==Patiënt R. XXX_Strengersz== | ||
<section begin=XXX_Strengersz /> | <section begin=XXX_Strengersz /> | ||
− | + | {| class="wikitable" width="85%" | |
− | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patient | |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
|style="background-color: white;"|R. XXX_Strengersz | |style="background-color: white;"|R. XXX_Strengersz | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
|style="background-color: white;"|999911338 [BSN] | |style="background-color: white;"|999911338 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
|style="background-color: white;"|41106 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|41106 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geboortedatum |
|style="background-color: white;"|1 aug 1964 | |style="background-color: white;"|1 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geslacht |
|style="background-color: white;"|Vrouw (code = 'F') | |style="background-color: white;"|Vrouw (code = 'F') | ||
|}<section end=XXX_Strengersz /> | |}<section end=XXX_Strengersz /> | ||
Regel 3.800: | Regel 3.800: | ||
<section begin=MA_XXX_Strengersz /> | <section begin=MA_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_1_MA_1 | |style="background-color: white;"|MBH_413_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 11:25 | |style="background-color: white;"|3 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_1 | |style="background-color: white;"|MBH_413_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_2_MA_1 | |style="background-color: white;"|MBH_413_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 11:25 | |style="background-color: white;"|3 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml | + | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid | |style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_2 | |style="background-color: white;"|MBH_413_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_3_MA_1 | |style="background-color: white;"|MBH_413_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|15 jul 2018, om 11:25 | |style="background-color: white;"|15 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag 1 à 2 stuks | |style="background-color: white;"|3 maal per dag 1 à 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_3 | |style="background-color: white;"|MBH_413_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_4_MA_1 | |style="background-color: white;"|MBH_413_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|14 aug 2018, om 10:26 | |style="background-color: white;"|14 aug 2018, om 10:26 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Cutaan (code = '7') | |style="background-color: white;"|Cutaan (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag | |style="background-color: white;"|3 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_4 | |style="background-color: white;"|MBH_413_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_5_MA_1 | |style="background-color: white;"|MBH_413_5_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|14 aug 2018, om 10:46 | |style="background-color: white;"|14 aug 2018, om 10:46 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Ibuprofen PCH tablet 600mg | + | |style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '641898') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 0.25 stuk | |style="background-color: white;"|2 maal per dag 0.25 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_5 | |style="background-color: white;"|MBH_413_5 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_6_MA_1 | |style="background-color: white;"|MBH_413_6_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Waterstofperoxide 30MG/ML | + | |style="background-color: white;"|Waterstofperoxide 30MG/ML (code = '67016') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Niet van toepassing (code = '1') | |style="background-color: white;"|Niet van toepassing (code = '1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Eerst oplossen in water (code = '27') | |style="background-color: white;"|Eerst oplossen in water (code = '27') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69') | |style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 10 à 15 ml | |style="background-color: white;"|2 maal per dag 10 à 15 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_6 | |style="background-color: white;"|MBH_413_6 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_7_MA_1 | |style="background-color: white;"|MBH_413_7_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml | + | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid | |style="background-color: white;"|Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_7 | |style="background-color: white;"|MBH_413_7 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_8_MA_1 | |style="background-color: white;"|MBH_413_8_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Voor de nacht (code = '1128') | |style="background-color: white;"|Voor de nacht (code = '1128') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Op maandag, woensdag en vrijdag | |style="background-color: white;"|Op maandag, woensdag en vrijdag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_8 | |style="background-color: white;"|MBH_413_8 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_9_MA_1 | |style="background-color: white;"|MBH_413_9_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 | + | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, 1 maal daags 1 stuk ’s avonds innemen, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk 's avonds | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_9 | |style="background-color: white;"|MBH_413_9 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_10_MA_1 | |style="background-color: white;"|MBH_413_10_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) | + | |style="background-color: white;"|Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk | |style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Herhaalperiode cyclisch schema |
|style="background-color: white;"|28 dagen | |style="background-color: white;"|28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_10 | |style="background-color: white;"|MBH_413_10 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_11_MA_1 | |style="background-color: white;"|MBH_413_11_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Fusidinezuur creme 20mg/g | + | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Cutaan (code = '7') | |style="background-color: white;"|Cutaan (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Dun aanbrengen (code = '1033') | |style="background-color: white;"|Dun aanbrengen (code = '1033') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie 1 | + | |colspan="2"|Doseerinstructie 1 |
|style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram | |style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie 2 | + | |colspan="2"|Doseerinstructie 2 |
|style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram | |style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie 3 | + | |colspan="2"|Doseerinstructie 3 |
|style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram | |style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_11 | |style="background-color: white;"|MBH_413_11 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_12_MA_1 | |style="background-color: white;"|MBH_413_12_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 11:25 | |style="background-color: white;"|3 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) | + | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk | |style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_12 | |style="background-color: white;"|MBH_413_12 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_13_MA_1 | |style="background-color: white;"|MBH_413_13_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|6 aug 2018, om 09:12 | |style="background-color: white;"|6 aug 2018, om 09:12 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen | |style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML | + | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen, 0.5 ml per uur parenteraal | |style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen, 0.5 ml per uur parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Parenteraal (code = '10') | |style="background-color: white;"|Parenteraal (code = '10') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|0.5 ml per uur | |style="background-color: white;"|0.5 ml per uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_13 | |style="background-color: white;"|MBH_413_13 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_13_MA_2 | |style="background-color: white;"|MBH_413_13_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|14 aug 2018, om 11:25 | |style="background-color: white;"|14 aug 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML | + | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Parenteraal (code = '10') | |style="background-color: white;"|Parenteraal (code = '10') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|0.2 à 0.5 ml per uur | |style="background-color: white;"|0.2 à 0.5 ml per uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_13 | |style="background-color: white;"|MBH_413_13 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_14_MA_1 | |style="background-color: white;"|MBH_413_14_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 11:25 | |style="background-color: white;"|3 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Tot nader order | |style="background-color: white;"|Tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) | + | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | |style="background-color: white;"|Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Transdermaal (code = '58') | |style="background-color: white;"|Transdermaal (code = '58') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_14 | |style="background-color: white;"|MBH_413_14 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_15_MA_1 | |style="background-color: white;"|MBH_413_15_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden afspraak |
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - Product specificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |rowspan="16"| |
− | |style="background-color: white;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="2"|Product naam | ||
+ | |style="background-color: white;"|Haparine 100 ie= 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Farmaceutische vorm | ||
+ | |style="background-color: white;"|Vloeistof (code = '434') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|Heparinum natricum (code = '898724') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|100 internationale eenheid per 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Gebruiksinstructie | + | |colspan="3"|Ingredient |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|1 stuk per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|NATRII CHLORIDUM (code = '256390') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|0.09 gram per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Parenteraal (code = '10') | |style="background-color: white;"|Parenteraal (code = '10') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 10 ml | |style="background-color: white;"|2 maal per dag 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_15 | |style="background-color: white;"|MBH_413_15 | ||
|}<section end=MA_XXX_Strengersz /> | |}<section end=MA_XXX_Strengersz /> | ||
Regel 4.485: | Regel 4.525: | ||
<section begin=VV_XXX_Strengersz /> | <section begin=VV_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_15_VV_1 | |style="background-color: white;"|MBH_413_15_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Te verstrekken hoeveelheid |
|style="background-color: white;"|100 ml | |style="background-color: white;"|100 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aantal herhalingen |
|style="background-color: white;"|1 | |style="background-color: white;"|1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - Product specificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="16"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Product naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Haparine 100 ie= 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Farmaceutische vorm |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vloeistof (code = '434') |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | + | |colspan="3"|Ingredient | |
− | |||
− | |||
− | |style=" | ||
− | |||
− | |colspan=" | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | ||Ingredient code |
+ | |style="background-color: white;"|Heparinum natricum (code = '898724') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|100 internationale eenheid per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|1 stuk per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|NATRII CHLORIDUM (code = '256390') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|0.09 gram per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Beoogd verstrekker | ||
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_413_15_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_15 | ||
+ | |}<section end=VV_XXX_Strengersz /> | ||
+ | ===Toedieningsafspraken XXX_Strengersz === | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_1_TA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 11:25 | |style="background-color: white;"|3 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_1_MA_1 | |style="background-color: white;"|MBH_413_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_1 | |style="background-color: white;"|MBH_413_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_2_TA_1 | |style="background-color: white;"|MBH_413_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 11:25 | |style="background-color: white;"|3 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|HUMULINE NPH INJ 100IE/ML PATROON 3ML | + | |style="background-color: white;"|HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid | |style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_2_MA_1 | |style="background-color: white;"|MBH_413_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_2 | |style="background-color: white;"|MBH_413_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_3_TA_1 | |style="background-color: white;"|MBH_413_3_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|15 jul 2018, om 11:25 | |style="background-color: white;"|15 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag 1 à 2 stuks | |style="background-color: white;"|3 maal per dag 1 à 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_3_MA_1 | |style="background-color: white;"|MBH_413_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_3 | |style="background-color: white;"|MBH_413_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_4_TA_1 | |style="background-color: white;"|MBH_413_4_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|14 aug 2018, om 10:26 | |style="background-color: white;"|14 aug 2018, om 10:26 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON | + | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Cutaan (code = '7') | |style="background-color: white;"|Cutaan (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag | |style="background-color: white;"|3 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_4_MA_1 | |style="background-color: white;"|MBH_413_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_4 | |style="background-color: white;"|MBH_413_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_5_TA_1 | |style="background-color: white;"|MBH_413_5_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|14 aug 2018, om 10:46 | |style="background-color: white;"|14 aug 2018, om 10:46 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Ibuprofen PCH tablet 600mg | + | |style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '641898') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 0.25 stuk | |style="background-color: white;"|2 maal per dag 0.25 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_5_MA_1 | |style="background-color: white;"|MBH_413_5_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_5 | |style="background-color: white;"|MBH_413_5 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_6_TA_1 | |style="background-color: white;"|MBH_413_6_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|SOLUTIO HYDROGENII PEROXIDI 3% M/V | + | |style="background-color: white;"|SOLUTIO HYDROGENII PEROXIDI 3% M/V (code = '603694') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Niet van toepassing (code = '1') | |style="background-color: white;"|Niet van toepassing (code = '1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Eerst oplossen in water (code = '27') | |style="background-color: white;"|Eerst oplossen in water (code = '27') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69') | |style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 10 à 15 ml | |style="background-color: white;"|2 maal per dag 10 à 15 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_6_MA_1 | |style="background-color: white;"|MBH_413_6_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_6 | |style="background-color: white;"|MBH_413_6 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_7_TA_1 | |style="background-color: white;"|MBH_413_7_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|HUMULINE NPH INJ 100IE/ML PATROON 3ML | + | |style="background-color: white;"|HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE, subcutaan | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE, subcutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid | |style="background-color: white;"|Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_7_MA_1 | |style="background-color: white;"|MBH_413_7_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_7 | |style="background-color: white;"|MBH_413_7 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_8_TA_1 | |style="background-color: white;"|MBH_413_8_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET | + | |style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET (code = '1198521') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Voor de nacht (code = '1128') | |style="background-color: white;"|Voor de nacht (code = '1128') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Op maandag, woensdag en vrijdag | |style="background-color: white;"|Op maandag, woensdag en vrijdag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_8_MA_1 | |style="background-color: white;"|MBH_413_8_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_8 | |style="background-color: white;"|MBH_413_8 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_9_TA_1 | |style="background-color: white;"|MBH_413_9_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|INEGY TABLET 10/20MG | + | |style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk 's avonds | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_9_MA_1 | |style="background-color: white;"|MBH_413_9_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_9 | |style="background-color: white;"|MBH_413_9 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_10_TA_1 | |style="background-color: white;"|MBH_413_10_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|MARVELON TABLET | + | |style="background-color: white;"|MARVELON TABLET (code = '416681') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk | |style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Herhaalperiode cyclisch schema |
|style="background-color: white;"|28 dagen | |style="background-color: white;"|28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_10_MA_1 | |style="background-color: white;"|MBH_413_10_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_10 | |style="background-color: white;"|MBH_413_10 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_11_TA_1 | |style="background-color: white;"|MBH_413_11_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|FUCIDIN CREME 20MG/G | + | |style="background-color: white;"|FUCIDIN CREME 20MG/G (code = '420956') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Cutaan (code = '7') | |style="background-color: white;"|Cutaan (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Dun aanbrengen (code = '1033') | |style="background-color: white;"|Dun aanbrengen (code = '1033') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie 1 | + | |colspan="2"|Doseerinstructie 1 |
|style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram | |style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie 2 | + | |colspan="2"|Doseerinstructie 2 |
|style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram | |style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie 3 | + | |colspan="2"|Doseerinstructie 3 |
|style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram | |style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_11_MA_1 | |style="background-color: white;"|MBH_413_11_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_11 | |style="background-color: white;"|MBH_413_11 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_12_TA_1 | |style="background-color: white;"|MBH_413_12_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 11:25 | |style="background-color: white;"|3 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG | + | |style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG (code = '874965') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk | |style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_12_MA_1 | |style="background-color: white;"|MBH_413_12_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_12 | |style="background-color: white;"|MBH_413_12 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_13_TA_1 | |style="background-color: white;"|MBH_413_13_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|6 aug 2018, om 09:12 | |style="background-color: white;"|6 aug 2018, om 09:12 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen | |style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA | + | |style="background-color: white;"|MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen, 0.5 ml per uur parenteraal | |style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen, 0.5 ml per uur parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Parenteraal (code = '10') | |style="background-color: white;"|Parenteraal (code = '10') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|0.5 ml per uur | |style="background-color: white;"|0.5 ml per uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_13_MA_1 | |style="background-color: white;"|MBH_413_13_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_13 | |style="background-color: white;"|MBH_413_13 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_13_TA_2 | |style="background-color: white;"|MBH_413_13_TA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|14 aug 2018, om 11:25 | |style="background-color: white;"|14 aug 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA | + | |style="background-color: white;"|MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Parenteraal (code = '10') | |style="background-color: white;"|Parenteraal (code = '10') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|0.2 à 0.5 ml per uur | |style="background-color: white;"|0.2 à 0.5 ml per uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_13_MA_2 | |style="background-color: white;"|MBH_413_13_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_13 | |style="background-color: white;"|MBH_413_13 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_14_TA_1 | |style="background-color: white;"|MBH_413_14_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 11:25 | |style="background-color: white;"|3 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 16 aug 2018, tot nader order | |style="background-color: white;"|Vanaf 16 aug 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG | + | |style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | |style="background-color: white;"|Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Transdermaal (code = '58') | |style="background-color: white;"|Transdermaal (code = '58') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
|style="background-color: white;"|MBH_413_14_MA_1 | |style="background-color: white;"|MBH_413_14_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_14 | |style="background-color: white;"|MBH_413_14 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_15_TA_1 | |style="background-color: white;"|MBH_413_15_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afspraakdatum |
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="16"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Product naam | ||
+ | |style="background-color: white;"|Haparine 100 ie= 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Farmaceutische vorm |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vloeistof (code = '434') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | || | + | ||Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Heparinum natricum (code = '898724') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | || | + | ||Sterkte |
− | |style="background-color: white;"| | + | |style="background-color: white;"|100 internationale eenheid per 10 ml |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"|MBH identificatie | + | ||Sterkte |
− | |style="background-color: white;"|MBH_413_15 | + | |style="background-color: white;"|1 stuk per 10 ml |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|NATRII CHLORIDUM (code = '256390') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|0.09 gram per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Parenteraal (code = '10') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|2 maal per dag 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_413_15_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_15 | ||
|} | |} | ||
===Verstrekkingen XXX_Strengersz === | ===Verstrekkingen XXX_Strengersz === | ||
<section begin=MVE_XXX_Strengersz /> | <section begin=MVE_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_9_MVE_1 | |style="background-color: white;"|MBH_413_9_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|3 sep 2018, om 10:35 | |style="background-color: white;"|3 sep 2018, om 10:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekte hoeveelheid |
|style="background-color: white;"|90 stuks | |style="background-color: white;"|90 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|INEGY TABLET 10/20MG | + | |style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Distributievorm |
|style="background-color: white;"|Geïndividualiseerd distributiesysteem (code = '1') | |style="background-color: white;"|Geïndividualiseerd distributiesysteem (code = '1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_9 | |style="background-color: white;"|MBH_413_9 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_15_MVE_1 | |style="background-color: white;"|MBH_413_15_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
|style="background-color: white;"|3 sep 2018, om 10:35 | |style="background-color: white;"|3 sep 2018, om 10:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekker |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekte hoeveelheid |
|style="background-color: white;"|100 ml | |style="background-color: white;"|100 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="16"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Product naam | ||
+ | |style="background-color: white;"|Haparine 100 ie= 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Farmaceutische vorm | ||
+ | |style="background-color: white;"|Vloeistof (code = '434') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Heparinum natricum (code = '898724') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | ||Sterkte |
+ | |style="background-color: white;"|100 internationale eenheid per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|1 stuk per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|NATRII CHLORIDUM (code = '256390') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|0.09 gram per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar verstrekkingsverzoek | ||
|style="background-color: white;"|MBH_513_15_VV_1 | |style="background-color: white;"|MBH_513_15_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_15 | |style="background-color: white;"|MBH_413_15 | ||
|}<section end=MVE_XXX_Strengersz /> | |}<section end=MVE_XXX_Strengersz /> | ||
Regel 5.264: | Regel 5.424: | ||
<section begin=MGB_XXX_Strengersz /> | <section begin=MGB_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_1_MGB_1 | |style="background-color: white;"|MBH_413_1_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 sep 2018, om 16:25 | |style="background-color: white;"|3 sep 2018, om 16:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_413_1_MA_1 | |style="background-color: white;"|MBH_413_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_1 | |style="background-color: white;"|MBH_413_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_2_MGB_1 | |style="background-color: white;"|MBH_413_2_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 sep 2018, om 14:25 | |style="background-color: white;"|3 sep 2018, om 14:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml | + | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, exact iedere 3 uur 16 IE, subcutaan | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid | |style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_413_2_MA_1 | |style="background-color: white;"|MBH_413_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_2 | |style="background-color: white;"|MBH_413_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_3_MGB_1 | |style="background-color: white;"|MBH_413_3_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 sep 2018, om 10:45 | |style="background-color: white;"|3 sep 2018, om 10:45 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag 1 à 2 stuks | |style="background-color: white;"|3 maal per dag 1 à 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_413_3_MA_1 | |style="background-color: white;"|MBH_413_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_3 | |style="background-color: white;"|MBH_413_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_4_MGB_1 | |style="background-color: white;"|MBH_413_4_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|19 aug 2018, om 13:44 | |style="background-color: white;"|19 aug 2018, om 13:44 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 14 aug 2018, tot en met 19 aug 2018 23:59 | |style="background-color: white;"|Vanaf 14 aug 2018, tot en met 19 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 14 aug 2018 tot en met 19 aug 2018, 3 maal per dag aanbrengen, cutaan | |style="background-color: white;"|Vanaf 14 aug 2018 tot en met 19 aug 2018, 3 maal per dag aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Cutaan (code = '7') | |style="background-color: white;"|Cutaan (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|3 maal per dag | |style="background-color: white;"|3 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_413_4_MA_1 | |style="background-color: white;"|MBH_413_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_4 | |style="background-color: white;"|MBH_413_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_5_MGB_1 | |style="background-color: white;"|MBH_413_5_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 sep 2018, om 12:38 | |style="background-color: white;"|3 sep 2018, om 12:38 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Ibuprofen PCH tablet 600mg | + | |style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '641898') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 0.25 stuk | |style="background-color: white;"|2 maal per dag 0.25 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_413_5_MA_1 | |style="background-color: white;"|MBH_413_5_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_5 | |style="background-color: white;"|MBH_413_5 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_6_MGB_1 | |style="background-color: white;"|MBH_413_6_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 sep 2018, om 21:37 | |style="background-color: white;"|3 sep 2018, om 21:37 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 1 dag | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 1 dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Waterstofperoxide 30MG/ML | + | |style="background-color: white;"|Waterstofperoxide 30MG/ML (code = '67016') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 1 dag, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 1 dag, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Niet van toepassing (code = '1') | |style="background-color: white;"|Niet van toepassing (code = '1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Eerst oplossen in water (code = '27') | |style="background-color: white;"|Eerst oplossen in water (code = '27') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69') | |style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 10 à 15 ml | |style="background-color: white;"|2 maal per dag 10 à 15 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_413_6_MA_1 | |style="background-color: white;"|MBH_413_6_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_6 | |style="background-color: white;"|MBH_413_6 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_7_MGB_1 | |style="background-color: white;"|MBH_413_7_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 sep 2018, om 14:05 | |style="background-color: white;"|3 sep 2018, om 14:05 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018 14:00, tot en met 3 sep 2018 14:05 | |style="background-color: white;"|Vanaf 3 sep 2018 14:00, tot en met 3 sep 2018 14:05 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml | + | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018 14:00 tot en met 3 sep 2018 14:05, om 14:00 16IE | |style="background-color: white;"|Vanaf 3 sep 2018 14:00 tot en met 3 sep 2018 14:05, om 14:00 16IE | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Elke dag om 16 internationale eenheid | |style="background-color: white;"|Elke dag om 16 internationale eenheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_413_7_MA_1 | |style="background-color: white;"|MBH_413_7_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_7 | |style="background-color: white;"|MBH_413_7 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_7_MGB_2 | |style="background-color: white;"|MBH_413_7_MGB_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 sep 2018, om 20:10 | |style="background-color: white;"|3 sep 2018, om 20:10 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018 20:00, tot en met 3 sep 2018 20:05 | |style="background-color: white;"|Vanaf 3 sep 2018 20:00, tot en met 3 sep 2018 20:05 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml | + | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018 20:00 tot en met 3 sep 2018 20:05, om 20:00 16IE | |style="background-color: white;"|Vanaf 3 sep 2018 20:00 tot en met 3 sep 2018 20:05, om 20:00 16IE | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Elke dag om 16 internationale eenheid | |style="background-color: white;"|Elke dag om 16 internationale eenheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_413_7_MA_1 | |style="background-color: white;"|MBH_413_7_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_7 | |style="background-color: white;"|MBH_413_7 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_8_MGB_1 | |style="background-color: white;"|MBH_413_8_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 sep 2018, om 23:59 | |style="background-color: white;"|3 sep 2018, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Voor de nacht (code = '1128') | |style="background-color: white;"|Voor de nacht (code = '1128') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Op maandag, woensdag en vrijdag | |style="background-color: white;"|Op maandag, woensdag en vrijdag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_413_8_MA_1 | |style="background-color: white;"|MBH_413_8_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_8 | |style="background-color: white;"|MBH_413_8 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_9_MGB_1 | |style="background-color: white;"|MBH_413_9_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 sep 2018, om 22:35 | |style="background-color: white;"|3 sep 2018, om 22:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 | + | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags ’s avonds innemen | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags ’s avonds innemen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk 's avonds | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_413_9_MA_1 | |style="background-color: white;"|MBH_413_9_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_9 | |style="background-color: white;"|MBH_413_9 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_10_MGB_1 | |style="background-color: white;"|MBH_413_10_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) | + | |style="background-color: white;"|Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk | |style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Herhaalperiode cyclisch schema |
|style="background-color: white;"|28 dagen | |style="background-color: white;"|28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_413_10_MA_1 | |style="background-color: white;"|MBH_413_10_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_10 | |style="background-color: white;"|MBH_413_10 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_11_MGB_1 | |style="background-color: white;"|MBH_413_11_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 sep 2018, om 15:35 | |style="background-color: white;"|3 sep 2018, om 15:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|Fusidinezuur creme 20mg/g | + | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Aanvullende instructie | + | |colspan="2"|Aanvullende instructie |
|style="background-color: white;"|Dun aanbrengen (code = '1033') | |style="background-color: white;"|Dun aanbrengen (code = '1033') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie 1 | + | |colspan="2"|Doseerinstructie 1 |
|style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram | |style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram | |style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram | |style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_413_11_MA_1 | |style="background-color: white;"|MBH_413_11_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_11 | |style="background-color: white;"|MBH_413_11 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_12_MGB_1 | |style="background-color: white;"|MBH_413_12_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 sep 2018, om 22:35 | |style="background-color: white;"|3 sep 2018, om 22:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) | + | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk | |style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_413_12_MA_1 | |style="background-color: white;"|MBH_413_12_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_12 | |style="background-color: white;"|MBH_413_12 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_14_MGB_1 | |style="background-color: white;"|MBH_413_14_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 sep 2018, om 22:35 | |style="background-color: white;"|3 sep 2018, om 22:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Tot nader order | |style="background-color: white;"|Tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) | + | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister). | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister). | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Transdermaal (code = '58') | |style="background-color: white;"|Transdermaal (code = '58') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_413_14_MA_1 | |style="background-color: white;"|MBH_413_14_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_14 | |style="background-color: white;"|MBH_413_14 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_413_15_MGB_1 | |style="background-color: white;"|MBH_413_15_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratiedatum |
|style="background-color: white;"|3 sep 2018, om 10:35 | |style="background-color: white;"|3 sep 2018, om 10:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|gebruiksperiode |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Voorschrijver |
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="16"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Product naam | ||
+ | |style="background-color: white;"|Haparine 100 ie= 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Farmaceutische vorm | ||
+ | |style="background-color: white;"|Vloeistof (code = '434') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|Heparinum natricum (code = '898724') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|100 internationale eenheid per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|1 stuk per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|NATRII CHLORIDUM (code = '256390') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Sterkte |
− | |style="background-color: white;"| | + | |style="background-color: white;"|0.09 gram per 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Omschrijving | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Toedieningsweg | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Parenteraal (code = '10') | |style="background-color: white;"|Parenteraal (code = '10') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | ||Doseerinstructie | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 10 ml | |style="background-color: white;"|2 maal per dag 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak: MA |
|style="background-color: white;"|MBH_413_15_MA_1 | |style="background-color: white;"|MBH_413_15_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_413_15 | |style="background-color: white;"|MBH_413_15 | ||
|}<section end=MGB_XXX_Strengersz /> | |}<section end=MGB_XXX_Strengersz /> |
Versie van 1 okt 2018 om 14:51
Deze pagina is nog in bewerking |
Inhoud
Addenda voor inhoudelijke gegevens
Patiënt J. XXX_Amaya
Patient | |||
Gegevenselement | Waarde | ||
Naamgegevens | J. XXX_Amaya | ||
Patient identificatienummer | 999911764 [BSN] | ||
Patient identificatienummer | 51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 6 aug 1964 | ||
Geslacht | Man (code = 'M') |
Medicatieafspraken XXX_Amaya
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_1 | ||
Afspraakdatum | 2 sep 2018, om 11:25 | ||
gebruiksperiode | Vanaf 2 sep 2018, gedurende 60 dagen | ||
Geannuleerd indicator | True | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 2 sep 2018, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 10 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_2 | ||
Afspraakdatum | 3 sep 2018, om 09:00 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 60 dagen | ||
Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MA_2 | ||
Afspraakdatum | 3 sep 2018, om 14:32 | ||
gebruiksperiode | Vanaf 3 sep 2018, tot nader order | ||
Relatie naar afspraak of gebruik: TA | MBH_513_2_TA_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007') | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Toelichting | Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | ||
MBH identificatie | MBH_513_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MA_1 | ||
Afspraakdatum | 3 sep 2018, om 14:32 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 28 dagen | ||
Relatie naar afspraak of gebruik: MGB | MBH_513_3_MGB_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007') | ||
Reden van voorschrijven | Andere maligniteit bloed/lymfestelsel (code = 'B74') | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
MBH identificatie | MBH_513_3 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MA_1 | ||
Afspraakdatum | 29 aug 2018, om 09:35 | ||
gebruiksperiode | Vanaf 29 aug 2018, gedurende 10 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 29 aug 2018, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Lichaamslengte | 155 cm | ||
Lichaamsgewicht | 54 kg | ||
Aanvullende informatie | Bewust hoge dosering (code = '1') | ||
Toelichting | In overleg met specialist | ||
MBH identificatie | MBH_513_4 |
Verstrekkingsverzoeken XXX_Amaya
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_VV_2 | ||
Datum | 16 aug 2018, om 14:32 | ||
Auteur | Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd | ||
Te verstrekken hoeveelheid | 30 stuks | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Toelichting | Nog in te vullen, zie word... | ||
Relatie naar medicatieafspraak | MBH_513_2_MA_2 | ||
MBH identificatie | MBH_513_2 |
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_VV_1 | ||
Datum | 11 aug 2018, om 09:35 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 40 stuks | ||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Afleverlocatie | Huisadres patiënt | ||
Aanvullende wensen | Bezorgen (code = '3') | ||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
MBH identificatie | MBH_513_4 |
Toedieningsafspraken XXX_Amaya
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_TA_1 | ||
Afspraakdatum | 3 sep 2018, om 12:25 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 60 dagen | ||
Geannuleerd indicator | True | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_513_1_MA_2 | ||
MBH identificatie | MBH_513_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_TA_1 | ||
Afspraakdatum | 27 aug 2018, om 14:52 | ||
gebruiksperiode | Vanaf 27 aug 2018, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Reden afspraak | Opname | ||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 27 aug 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_513_2_MA_1 | ||
MBH identificatie | MBH_513_2 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_TA_1 | ||
Afspraakdatum | 29 aug 2018, om 09:45 | ||
gebruiksperiode | Vanaf 29 aug 2018, gedurende 10 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 29 aug 2018, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Aanvullende informatie | Gebruiksinstructie gegeven (code = '10') | ||
Toelichting | Wegens niet leverbaar zijn van Broxil | ||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
MBH identificatie | MBH_513_4 |
Verstrekkingen XXX_Amaya
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MVE_1 | ||
Aanschrijfdatum | 3 sep 2018, om 14:32 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148') | ||
Relatie naar verstrekkingsverzoek | MBH_513_2_VV_2 | ||
MBH identificatie | MBH_513_2 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MVE_1 | ||
Datum | 29 aug 2018, om 09:45 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083') | ||
Afleverlocatie | Huisadres patiënt | ||
Aanvullende informatie | Aantal bewust gewijzigd (code = '1') | ||
Toelichting | Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. | ||
Relatie naar verstrekkingsverzoek | MBH_513_4_VV_1 | ||
MBH identificatie | MBH_513_4 |
Medicatiegebruik XXX_Amaya
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_1 | ||
Registratiedatum | 1 sep 2018, om 15:39 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 1 sep 2018, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 1 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak: MA | MBH_513_2_MA_1 | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_2 | ||
Registratiedatum | 3 sep 2018, om 20:40 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 2 sep 2018, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 2 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak: MA | MBH_513_2_MA_1 | ||
Informant | Persoon: M. XXX_Amaya - Mantelzorger. | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_3 | ||
Registratiedatum | 3 sep 2018, om 21:39 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 3 sep 2018, tot nader order | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak: MA | MBH_513_2_MA_1 | ||
Informant | Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_5132_2_MGB_2 | ||
Registratiedatum | 16 aug 2018, om 20:59 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 16 aug 2018, gedurende 1 dag | ||
Geneesmiddel | TEMAZEPAM APOTEX TABLET 10MG (code = '13806769') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 1 dag, 1 maal daags 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde verstrekking | MBH_5132_2_MVE_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_5132_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MGB_1 | ||
Registratiedatum | 31 aug 2018, om 20:59 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 26 aug 2018, tot en met 31 aug 2018 23:59 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 26 aug 2018 tot en met 31 aug 2018, 1 maal per week 5 stuks, oraal | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
Gerelateerde afspraak: MA | MBH_513_3_MA_1 | ||
Auteur | Patiënt | ||
Reden gebruik | Lymfekanker | ||
MBH identificatie | MBH_513_3 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MGB_1 | ||
Registratiedatum | 30 aug 2018, om 22:35 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | False | ||
gebruiksperiode | Vanaf 29 aug 2018, tot en met 30 aug 2018 23:59 | ||
Geneesmiddel | AMOXICILLINE CAPSULE 250MG (code = '20044') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 29 aug 2018 tot en met 30 aug 2018, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak: MA | MBH_513_4_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_513_4 |
Patiënt Pauline P. XXX_Bourgonje
Patient | |||
Gegevenselement | Waarde | ||
Naamgegevens | Pauline P. XXX_Bourgonje | ||
Patient identificatienummer | 999911296 [BSN] | ||
Patient identificatienummer | 12102 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 1 aug 1964 | ||
Geslacht | Vrouw (code = 'F') |
Medicatieafspraken XXX_Bourgonje
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_123_1_MA_1 | ||
Afspraakdatum | 27 aug 2018, om | ||
gebruiksperiode | Vanaf 27 aug 2018, tot nader order | ||
Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '133329') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 27 aug 2018, Zo nodig 2 maal daags aanbrengen, op de huid | ||
Toedieningsweg | Cutaan (code = '53') | ||
Aanvullende instructie | Aanbrengen (code = '1018') | ||
Doseerinstructie | Zo nodig 2 maal per dag | ||
MBH identificatie | MBH_123_1 |
Verstrekkingsverzoeken XXX_Bourgonje
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_123_1_VV_1 | ||
Datum | 27 aug 2018, om | ||
Auteur | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||
Te verstrekken hoeveelheid | 100 gram | ||
Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '133329') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Relatie naar medicatieafspraak | MBH_123_1_MA_1 | ||
MBH identificatie | MBH_123_1 |
Toedieningsafspraken XXX_Bourgonje
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_123_1_TA_1 | ||
Afspraakdatum | 27 aug 2018, om 00:00 | ||
gebruiksperiode | Vanaf 27 aug 2018, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 27 aug 2018, Zo nodig 2 maal daags aanbrengen, op de huid | ||
Toedieningsweg | Cutaan (code = '53') | ||
Aanvullende instructie | Aanbrengen (code = '1018') | ||
Doseerinstructie | Zo nodig 2 maal per dag | ||
Relatie naar medicatieafspraak | MBH_123_1_MA_1 | ||
MBH identificatie | MBH_123_1 |
Verstrekkingen XXX_Bourgonje
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_123_1_MVE_1 | ||
Datum | 27 aug 2018, om | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 100 gram | ||
Geneesmiddel | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943') | ||
Relatie naar verstrekkingsverzoek | MBH_123_1_VV_1 | ||
MBH identificatie | MBH_123_1 |
Medicatiegebruik XXX_Bourgonje
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_123_1_MGB_1 | ||
Registratiedatum | 12 aug 2018, om 20:58 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 11 aug 2018, gedurende 2 dagen | ||
Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||
Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '133329') | ||
Gebruiksinstructie | |||
Aanvullende instructie | Aanbrengen (code = '1018') | ||
Doseerinstructie | 2 maal per dag | ||
Gerelateerde afspraak: MA | MBH_123_1_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_123_1 |
Patiënt J. XXX_Cnossen
Patient | |||
Gegevenselement | Waarde | ||
Naamgegevens | J. XXX_Cnossen | ||
Patient identificatienummer | 999911740 [BSN] | ||
Patient identificatienummer | 31105 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 4 aug 1964 | ||
Geslacht | Man (code = 'M') |
Medicatieafspraken XXX_Cnossen
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_1_MA_1 | ||
Afspraakdatum | 26 mei 2018, om 12:11 | ||
gebruiksperiode | Vanaf 26 mei 2018, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Tiotropium inhalatiecapsule 18ug (code = '59919') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
Toedieningsweg | Inhalatie (code = '62') | ||
Doseerinstructie | 1 maal per dag 1 dosis | ||
MBH identificatie | MBH_313_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_1_MA_2 | ||
Afspraakdatum | 5 jul 2018, om 13:54 | ||
gebruiksperiode | Vanaf 26 mei 2018, tot en met 6 jul 2018 23:59 | ||
Stoptype | Staking | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Indicatie vervallen (code = '9') | ||
Geneesmiddel | Tiotropium inhalatiecapsule 18ug (code = '59919') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 26 mei 2018 tot en met 6 jul 2018, 1 maal per dag 1 dosis, inhalatie | ||
Toedieningsweg | Inhalatie (code = '62') | ||
Doseerinstructie | 1 maal per dag 1 dosis | ||
MBH identificatie | MBH_313_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_2_MA_1 | ||
Afspraakdatum | 21 apr 2017, om 10:19 | ||
gebruiksperiode | Vanaf 21 apr 2017, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 21 apr 2017, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
Toedieningsweg | Oculair (code = '7') | ||
Aanvullende instructie | In beide ogen (code = '1026') | ||
Doseerinstructie | 1 maal per dag 1 druppel | ||
MBH identificatie | MBH_313_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_2_MA_2 | ||
Afspraakdatum | 2 sep 2017, om 17:54 | ||
gebruiksperiode | Vanaf 21 apr 2017, tot en met 2 sep 2017 17:00 | ||
Stoptype | Staking | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Indicatie vervallen (code = '9') | ||
Geneesmiddel | Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 21 apr 2017 tot en met 2 sep 2017 17:00, 1x per dag 1 druppel, in beide ogen | ||
Toedieningsweg | Oculair (code = '7') | ||
Aanvullende instructie | In beide ogen (code = '1026') | ||
Doseerinstructie | 1 maal per dag 1 druppel | ||
MBH identificatie | MBH_313_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_3_MA_1 | ||
Afspraakdatum | 26 mei 2018, om 12:11 | ||
gebruiksperiode | Vanaf 26 mei 2018, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | CARBASALAATCALCIUM 100MG PO (code = '13072') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_313_3 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_3_MA_2 | ||
Afspraakdatum | 30 aug 2018, om 13:54 | ||
gebruiksperiode | Vanaf 26 mei 2018, tot en met 29 aug 2018 23:59 | ||
Stoptype | Onderbreking | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | CARBASALAATCALCIUM 100MG PO (code = '13072') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 26 mei 2018 tot en met 29 aug 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_313_3 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_4_MA_1 | ||
Afspraakdatum | 7 nov 2017, om 14:23 | ||
gebruiksperiode | Vanaf 7 nov 2017, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Omeprazol tablet MSR 40mg (code = '88803') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 7 nov 2017, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_313_4 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_4_MA_2 | ||
Afspraakdatum | 24 jan 2018, om 08:54 | ||
gebruiksperiode | Vanaf 7 nov 2017, tot en met 23 jan 2018 23:59 | ||
Stoptype | Onderbreking | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Omeprazol tablet MSR 40mg (code = '88803') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 7 nov 2017 tot en met 23 jan 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_313_4 |
Toedieningsafspraken XXX_Cnossen
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_1_TA_1 | ||
Afspraakdatum | 26 mei 2018, om 12:11 | ||
gebruiksperiode | Vanaf 26 mei 2018, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | SPIRIVA INHALPDR 18MCG (code = '1476866') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
Toedieningsweg | Inhalatie (code = '62') | ||
Doseerinstructie | 1 maal per dag 1 dosis | ||
Relatie naar medicatieafspraak | MBH_313_1_MA_1 | ||
MBH identificatie | MBH_313_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_1_TA_2 | ||
Afspraakdatum | 5 jul 2018, om 13:54 | ||
gebruiksperiode | Vanaf 26 mei 2018, tot en met 6 jul 2018 23:59 | ||
Stoptype | Staking | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | SPIRIVA INHALPDR 18MCG (code = '1476866') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 26 mei 2018 tot en met 6 jul 2018, 1 maal per dag 1 dosis, inhalatie | ||
Toedieningsweg | Inhalatie (code = '62') | ||
Doseerinstructie | 1 maal per dag 1 dosis | ||
Relatie naar medicatieafspraak | MBH_313_1_MA_2 | ||
MBH identificatie | MBH_313_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_2_TA_1 | ||
Afspraakdatum | 21 apr 2017, om 10:19 | ||
gebruiksperiode | Vanaf 21 apr 2017, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 21 apr 2017, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
Toedieningsweg | Oculair (code = '7') | ||
Aanvullende instructie | In beide ogen (code = '1026') | ||
Doseerinstructie | 1 maal per dag 1 druppel | ||
Relatie naar medicatieafspraak | MBH_313_2_MA_1 | ||
MBH identificatie | MBH_313_2 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_2_TA_2 | ||
Afspraakdatum | 2 sep 2017, om 17:54 | ||
gebruiksperiode | Vanaf 21 apr 2017, tot en met 2 sep 2017 17:00 | ||
Stoptype | Staking | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 21 apr 2017 tot en met 2 sep 2017 17:00, 1x per dag 1 druppel, in beide ogen | ||
Toedieningsweg | Oculair (code = '7') | ||
Aanvullende instructie | In beide ogen (code = '1026') | ||
Doseerinstructie | 1 maal per dag 1 druppel | ||
Relatie naar medicatieafspraak | MBH_313_2_MA_2 | ||
MBH identificatie | MBH_313_2 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_3_TA_1 | ||
Afspraakdatum | 26 mei 2018, om 12:30 | ||
gebruiksperiode | Vanaf 26 mei 2018, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_313_3_MA_1 | ||
MBH identificatie | MBH_313_3 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_3_TA_2 | ||
Afspraakdatum | 30 aug 2018, om 14:54 | ||
gebruiksperiode | Vanaf 26 mei 2018, tot en met 29 aug 2018 23:59 | ||
Stoptype | Onderbreking | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 26 mei 2018 tot en met 29 aug 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_313_3_MA_2 | ||
MBH identificatie | MBH_313_3 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_4_TA_1 | ||
Afspraakdatum | 7 nov 2017, om 15:23 | ||
gebruiksperiode | Vanaf 7 nov 2017, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 7 nov 2017, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_313_4_MA_1 | ||
MBH identificatie | MBH_313_4 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_4_TA_2 | ||
Afspraakdatum | 24 jan 2018, om 09:54 | ||
gebruiksperiode | Vanaf 7 nov 2017, tot en met 23 jan 2018 23:59 | ||
Stoptype | Onderbreking | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 7 nov 2017 tot en met 23 jan 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_313_4_MA_2 | ||
MBH identificatie | MBH_313_4 |
Medicatiegebruik XXX_Cnossen
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_1_MGB_1 | ||
Registratiedatum | 6 jul 2018, om 12:11 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 6 jul 2018, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Tiotropium inhalatiecapsule 18ug (code = '59919') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T-100, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
Toedieningsweg | Inhalatie (code = '62') | ||
Doseerinstructie | 1 maal per dag 1 dosis | ||
Gerelateerde afspraak: MA | MBH_313_1_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_313_1 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_1_MGB_2 | ||
Registratiedatum | 18 jun 2018, om 15:25 | ||
Gebruik indicator | False | ||
gebruiksperiode | Vanaf 8 mei 2018, tot en met 18 jun 2018 23:59 | ||
Stoptype | Staking | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Tiotropium inhalatiecapsule 18ug (code = '59919') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T-100, tot en met T-59, 1 maal per dag 1 dosis, inhalatie | ||
Toedieningsweg | Inhalatie (code = '62') | ||
Doseerinstructie | 1 maal per dag 1 dosis | ||
Gerelateerde afspraak: MA | MBH_313_1_MA_2 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_313_1 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_2_MGB_1 | ||
Registratiedatum | 3 apr 2017, om 10:19 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 3 apr 2017, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T-500, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
Toedieningsweg | Oculair (code = '7') | ||
Aanvullende instructie | In beide ogen (code = '1026') | ||
Doseerinstructie | 1 maal per dag 1 druppel | ||
Gerelateerde afspraak: MA | MBH_313_2_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_313_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_2_MGB_2 | ||
Registratiedatum | 15 aug 2017, om 17:54 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 3 apr 2017, tot en met 15 aug 2017 17:00 | ||
Stoptype | Staking | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T-500, tot en met T-366 17:00, 1x per dag 1 druppel, in beide ogen | ||
Toedieningsweg | Oculair (code = '7') | ||
Aanvullende instructie | In beide ogen (code = '1026') | ||
Doseerinstructie | 1 maal per dag 1 druppel | ||
Gerelateerde afspraak: MA | MBH_313_2_MA_2 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_313_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_3_MGB_1 | ||
Registratiedatum | 8 mei 2018, om 12:11 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 8 mei 2018, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | CARBASALAATCALCIUM 100MG PO (code = '13072') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T-100, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak: MA | MBH_313_3_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_313_3 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_3_MGB_2 | ||
Registratiedatum | 12 aug 2017, om 13:54 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 8 mei 2018, tot en met 11 aug 2018 23:59 | ||
Stoptype | Onderbreking | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | CARBASALAATCALCIUM 100MG PO (code = '13072') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T-100, tot en met T-5, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-4 | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak: MA | MBH_313_3_MA_2 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_313_3 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_4_MGB_1 | ||
Registratiedatum | 20 okt 2017, om 14:23 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 20 okt 2017, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Omeprazol tablet MSR 40mg (code = '88803') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T-300, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak: MA | MBH_313_4_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_313_4 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_4_MGB_2 | ||
Registratiedatum | 6 jan 2018, om 08:54 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 20 okt 2017, tot en met 5 jan 2018 23:59 | ||
Stoptype | Onderbreking | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Omeprazol tablet MSR 40mg (code = '88803') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T-300, tot en met T-223, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-222 | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak: MA | MBH_313_4_MA_2 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_313_4 |
Patiënt R. XXX_Dirksz
Patient | |||
Gegevenselement | Waarde | ||
Naamgegevens | R. XXX_Dirksz | ||
Patient identificatienummer | 999911326 [BSN] | ||
Patient identificatienummer | 11101 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 1 aug 1964 | ||
Geslacht | Man (code = 'M') |
Medicatieafspraken XXX_Dirksz
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_1_MA_1 | ||
Afspraakdatum | 15 jul 2018, om 11:25 | ||
gebruiksperiode | Vanaf 15 jul 2018, gedurende 30 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Metoclopramide zetpil 20mg (code = '6939') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 15 jul 2018, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | ||
Toedieningsweg | Rectaal (code = '12') | ||
Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_113_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_2_MA_1 | ||
Afspraakdatum | 4 aug 2018, om 14:55 | ||
gebruiksperiode | Vanaf 4 aug 2018, gedurende 3 weken | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Zestril tabel 10mg (code = '615560') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_113_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_3_MA_1 | ||
Afspraakdatum | 4 aug 2018, om 14:57 | ||
gebruiksperiode | Vanaf 4 aug 2018, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 4 aug 2018, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_113_3 |
Verstrekkingsverzoeken XXX_Dirksz
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_1_VV_1 | ||
Datum | 15 jul 2018, om 11:25 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 30 stuks | ||
Geneesmiddel | Metoclopramide zetpil 20mg (code = '6939') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Relatie naar medicatieafspraak | MBH_113_1_MA_1 | ||
MBH identificatie | MBH_113_1 |
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_2_VV_1 | ||
Datum | 4 aug 2018, om 14:55 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 21 stuks | ||
Geneesmiddel | Zestril tabel 10mg (code = '615560') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Relatie naar medicatieafspraak | MBH_113_2_MA_1 | ||
MBH identificatie | MBH_113_2 |
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_3_VV_1 | ||
Datum | 4 aug 2018, om 14:57 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 21 stuks | ||
Geneesmiddel | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Relatie naar medicatieafspraak | MBH_113_3_MA_1 | ||
MBH identificatie | MBH_113_3 |
Toedieningsafspraken XXX_Dirksz
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_1_TA_1 | ||
Afspraakdatum | 15 jul 2018, om 11:25 | ||
gebruiksperiode | Vanaf 15 jul 2018, gedurende 30 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | PRIMPERAN ZETPIL 20MG (code = '229709') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 15 jul 2018, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | ||
Toedieningsweg | Rectaal (code = '12') | ||
Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_113_1_MA_1 | ||
MBH identificatie | MBH_113_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_2_TA_1 | ||
Afspraakdatum | 4 aug 2018, om 14:55 | ||
gebruiksperiode | Vanaf 4 aug 2018, gedurende 3 weken | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | Zestril tabel 10mg (code = '615560') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_113_2_MA_1 | ||
MBH identificatie | MBH_113_2 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_3_TA_1 | ||
Afspraakdatum | 4 aug 2018, om 14:57 | ||
gebruiksperiode | Vanaf 4 aug 2018, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ROTER APC TABLET (code = '202185') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 4 aug 2018, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_113_2_MA_1 | ||
MBH identificatie | MBH_113_3 |
Verstrekkingen XXX_Dirksz
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_1_MVE_1 | ||
Datum | 15 jul 2018, om 12:25 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | PRIMPERAN ZETPIL 20MG (code = '229709') | ||
Relatie naar verstrekkingsverzoek | MBH_113_1_VV_1 | ||
MBH identificatie | MBH_113_1 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_2_MVE_1 | ||
Datum | 4 aug 2018, om 15:55 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 25 stuks | ||
Geneesmiddel | Zestril tablet 10mg (code = '615560') | ||
Relatie naar verstrekkingsverzoek | MBH_113_2_VV_1 | ||
MBH identificatie | MBH_113_2 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_3_MVE_1 | ||
Datum | 4 aug 2018, om 15:56 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 21 stuks | ||
Geneesmiddel | ROTER APC TABLET (code = '202185') | ||
Relatie naar verstrekkingsverzoek | MBH_113_3_VV_1 | ||
MBH identificatie | MBH_113_3 |
Medicatiegebruik XXX_Dirksz
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_1_MGB_1 | ||
Registratiedatum | 17 jul 2018, om 11:25 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 17 jul 2018, gedurende 1 dag | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Metoclopramide zetpil 20mg (code = '6939') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 17 jul 2018, gedurende 1 dag, 1 maal per dag 1 stuk, rectaal | ||
Toedieningsweg | Rectaal (code = '12') | ||
Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | ||
Gerelateerde afspraak: MA | MBH_113_1_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_113_1 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_2_MGB_1 | ||
Registratiedatum | 21 aug 2018, om 14:55 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
gebruiksperiode | Vanaf 4 aug 2018, gedurende 3 weken | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Zestril tabel 10mg (code = '615560') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak: MA | MBH_113_2_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_113_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_3_MGB_1 | ||
Registratiedatum | 5 aug 2018, om 14:57 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 5 aug 2018, tot en met 26 aug 2018 23:59 | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 5 aug 2018 tot en met 26 aug 2018, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak: MA | MBH_113_3_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_113_3 |
Patiënt R. XXX_Gobee
Patient | |||
Gegevenselement | Waarde | ||
Naamgegevens | R. XXX_Gobee | ||
Patient identificatienummer | 999911314 [BSN] | ||
Patient identificatienummer | 21104 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 1 aug 1964 | ||
Geslacht | Vrouw (code = 'F') |
Medicatieafspraken XXX_Gobee
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MA_1 | ||
Afspraakdatum | 15 jul 2018, om 11:25 | ||
gebruiksperiode | Vanaf 15 jul 2018, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 15 jul 2018, gedurende 30 dagen, 1 à 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
MBH identificatie | MBH_213_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MA_2 | ||
Afspraakdatum | 25 jul 2018, om 09:13 | ||
gebruiksperiode | Vanaf 15 jul 2018, tot en met 24 jul 2018 23:59 | ||
Stoptype | Staking | ||
Relatie naar afspraak of gebruik: MA | MBH_213_1_MA_1 | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 15 jul 2018 tot en met 24 jul 2018, 1 à 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
MBH identificatie | MBH_213_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MA_3 | ||
Afspraakdatum | 25 jul 2018, om 09:13 | ||
gebruiksperiode | Vanaf 25 jul 2018, gedurende 30 dagen | ||
Relatie naar afspraak of gebruik: MA | MBH_213_1_MA_2 | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Geen of onvoldoende effect (code = '5') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 25 jul 2018, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 2 maal per dag 1 stuk | ||
MBH identificatie | MBH_213_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MA_4 | ||
Afspraakdatum | 19 aug 2018, om 09:13 | ||
gebruiksperiode | Vanaf 25 jul 2018, tot en met 19 aug 2018 23:59 | ||
Stoptype | Staking | ||
Relatie naar afspraak of gebruik: MA | MBH_213_1_MA_3 | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 25 jul 2018 tot en met 19 aug 2018, 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 2 maal per dag 1 stuk | ||
MBH identificatie | MBH_213_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MA_5 | ||
Afspraakdatum | 20 aug 2018, om 16:25 | ||
gebruiksperiode | Vanaf 20 aug 2018, gedurende 30 dagen | ||
Relatie naar afspraak of gebruik: MA | MBH_213_1_MA_4 | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Wens patiënt (code = '12') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 20 aug 2018, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_213_1 |
Verstrekkingsverzoeken XXX_Gobee
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_VV_1 | ||
Datum | 15 jul 2018, om 11:25 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 40 stuks | ||
Aantal herhalingen | 1 | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Relatie naar medicatieafspraak | MBH_213_1_MA_1 | ||
MBH identificatie | MBH_213_1 |
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_VV_2 | ||
Datum | 25 jul 2018, om 09:13 | ||
Auteur | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 60 stuks | ||
Aantal herhalingen | 1 | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Relatie naar medicatieafspraak | MBH_213_1_MA_3 | ||
MBH identificatie | MBH_213_1 |
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_VV_3 | ||
Datum | 19 aug 2018, om 16:25 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Verbruiksperiode | Vanaf 1 aug 2018, gedurende 30 dagen | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Relatie naar medicatieafspraak | MBH_213_1_MA_5 | ||
MBH identificatie | MBH_213_1 |
Toedieningsafspraken XXX_Gobee
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_TA_1 | ||
Afspraakdatum | 15 jul 2018, om 11:25 | ||
gebruiksperiode | Vanaf 15 jul 2018, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 15 jul 2018, gedurende 30 dagen, 1 à 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_213_1_MA_1 | ||
MBH identificatie | MBH_213_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_TA_2 | ||
Afspraakdatum | 25 jul 2018, om 09:13 | ||
gebruiksperiode | Vanaf 15 jul 2018, tot en met 24 jul 2018 23:59 | ||
Stoptype | Staking | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 15 jul 2018 tot en met 24 jul 2018, 1 à 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_213_1_MA_2 | ||
MBH identificatie | MBH_213_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_TA_3 | ||
Afspraakdatum | 25 jul 2018, om 09:13 | ||
gebruiksperiode | Vanaf 25 jul 2018, gedurende 30 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 25 jul 2018, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 2 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_213_1_MA_3 | ||
MBH identificatie | MBH_213_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_TA_4 | ||
Afspraakdatum | 19 aug 2018, om 09:13 | ||
gebruiksperiode | Vanaf 25 jul 2018, tot en met 19 aug 2018 23:59 | ||
Stoptype | Staking | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 25 jul 2018 tot en met 19 aug 2018, 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 2 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_213_1_MA_4 | ||
MBH identificatie | MBH_213_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_TA_5 | ||
Afspraakdatum | 19 aug 2018, om 16:25 | ||
gebruiksperiode | Vanaf 20 aug 2018, gedurende 30 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 20 aug 2018, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_213_1_MA_5 | ||
MBH identificatie | MBH_213_1 |
Verstrekkingen XXX_Gobee
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MVE_1 | ||
Datum | 15 jul 2018, om 13:25 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 40 stuks | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
Relatie naar verstrekkingsverzoek | MBH_213_1_VV_1 | ||
MBH identificatie | MBH_213_1 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MVE_2 | ||
Datum | 25 jul 2018, om 09:13 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 60 stuks | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
Relatie naar verstrekkingsverzoek | MBH_213_1_VV_2 | ||
MBH identificatie | MBH_213_1 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MVE_3 | ||
Datum | 19 aug 2018, om 17:25 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
Verbruiksduur | 30 dagen | ||
Relatie naar verstrekkingsverzoek | MBH_213_1_VV_2 | ||
MBH identificatie | MBH_213_1 |
Medicatiegebruik XXX_Gobee
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MGB_1 | ||
Registratiedatum | 18 jul 2018, om 11:25 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 15 jul 2018, gedurende 3 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 15 jul 2018, gedurende 3 dagen, 1 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak: MA | MBH_213_1_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_213_1 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MGB_2 | ||
Registratiedatum | 24 jul 2018, om 11:25 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 19 jul 2018, gedurende 6 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 19 jul 2018, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 2 maal per dag 1 stuk | ||
Gerelateerde afspraak: MA | MBH_213_1_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_213_1 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MGB_3 | ||
Registratiedatum | 30 jul 2018, om 19:25 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 25 jul 2018, gedurende 6 dagen | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 25 jul 2018, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 2 maal per dag 1 stuk | ||
Gerelateerde afspraak: TA | MBH_213_1_TA_3 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_213_1 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MGB_4 | ||
Registratiedatum | 18 aug 2018, om 11:25 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 31 jul 2018, gedurende 19 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 31 jul 2018, gedurende 19 dagen, 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 2 maal per dag 1 stuk | ||
Gerelateerde afspraak: MA | MBH_213_1_MA_3 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_213_1 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MGB_5 | ||
Registratiedatum | 24 aug 2018, om 11:25 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 20 aug 2018, gedurende 5 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 20 aug 2018, gedurende 5 dagen, 1 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak: MA | MBH_213_1_MA_5 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_213_1 |
Patiënt J. XXX_Kilkenny
Patient | |||
Gegevenselement | Waarde | ||
Naamgegevens | J. XXX_Kilkenny | ||
Patient identificatienummer | 999911752 [BSN] | ||
Patient identificatienummer | 22108 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 5 aug 1964 | ||
Geslacht | Vrouw (code = 'F') |
Medicatieafspraken XXX_Kilkenny
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_323_1_MA_1 | ||
Afspraakdatum | 29 aug 2018, om 15:34 | ||
gebruiksperiode | Vanaf 14 aug 2018, tot en met 28 aug 2018 23:59 | ||
Stoptype | Staking | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 14 aug 2018 tot en met 28 aug 2018, 3x per dag 1 tablet | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
MBH identificatie | MBH_323_1 |
Medicatiegebruik XXX_Kilkenny
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_323_1_MGB_1 | ||
Registratiedatum | 24 aug 2018, om 11:25 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 14 aug 2018, tot nader order | ||
Geneesmiddel | ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 14 aug 2018, 3x per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_323_1 |
Patiënt R. XXX_Ruys
Patient | |||
Gegevenselement | Waarde | ||
Naamgegevens | R. XXX_Ruys | ||
Patient identificatienummer | 999911351 [BSN] | ||
Patient identificatienummer | 13103 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 1 aug 1964 | ||
Geslacht | Man (code = 'M') |
Patiënt R. XXX_Strengersz
Patient | |||
Gegevenselement | Waarde | ||
Naamgegevens | R. XXX_Strengersz | ||
Patient identificatienummer | 999911338 [BSN] | ||
Patient identificatienummer | 41106 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 1 aug 1964 | ||
Geslacht | Vrouw (code = 'F') |
Medicatieafspraken XXX_Strengersz
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_1_MA_1 | ||
Afspraakdatum | 3 sep 2018, om 11:25 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 60 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
MBH identificatie | MBH_413_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_2_MA_1 | ||
Afspraakdatum | 3 sep 2018, om 11:25 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 60 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
Toedieningsweg | Subcutaan (code = '21') | ||
Doseerinstructie | Exact iedere 3 uur 16 internationale eenheid | ||
MBH identificatie | MBH_413_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_3_MA_1 | ||
Afspraakdatum | 15 jul 2018, om 11:25 | ||
gebruiksperiode | Vanaf 15 jul 2018, gedurende 7 weken | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 3 maal per dag 1 à 2 stuks | ||
MBH identificatie | MBH_413_3 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_4_MA_1 | ||
Afspraakdatum | 14 aug 2018, om 10:26 | ||
gebruiksperiode | Vanaf 14 aug 2018, gedurende 30 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '92789') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 14 aug 2018, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | ||
Toedieningsweg | Cutaan (code = '7') | ||
Aanvullende instructie | Aanbrengen (code = '1018') | ||
Doseerinstructie | 3 maal per dag | ||
MBH identificatie | MBH_413_4 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_5_MA_1 | ||
Afspraakdatum | 14 aug 2018, om 10:46 | ||
gebruiksperiode | Vanaf 14 aug 2018, gedurende 30 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Ibuprofen PCH tablet 600mg (code = '641898') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 2 maal per dag 0.25 stuk | ||
MBH identificatie | MBH_413_5 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_6_MA_1 | ||
Afspraakdatum | 3 sep 2018, om 09:35 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 14 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Waterstofperoxide 30MG/ML (code = '67016') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
Toedieningsweg | Niet van toepassing (code = '1') | ||
Aanvullende instructie | Eerst oplossen in water (code = '27') | ||
Aanvullende instructie | Mond spoelen, daarna uitspugen (code = '69') | ||
Doseerinstructie | 2 maal per dag 10 à 15 ml | ||
MBH identificatie | MBH_413_6 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_7_MA_1 | ||
Afspraakdatum | 3 sep 2018, om 09:35 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 14 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE | ||
Toedieningsweg | Subcutaan (code = '21') | ||
Doseerinstructie | Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid | ||
MBH identificatie | MBH_413_7 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_8_MA_1 | ||
Afspraakdatum | 3 sep 2018, om 09:35 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 10 weken | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | IMIQUIMOD 50MG/G CREME (code = '55050') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen | ||
Toedieningsweg | Subcutaan (code = '21') | ||
Aanvullende instructie | Voor de nacht (code = '1128') | ||
Aanvullende instructie | Aanbrengen (code = '1018') | ||
Doseerinstructie | Op maandag, woensdag en vrijdag | ||
MBH identificatie | MBH_413_8 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_9_MA_1 | ||
Afspraakdatum | 3 sep 2018, om 09:35 | ||
gebruiksperiode | Vanaf 3 sep 2018, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | EZETIMIB/SIMVASTATINE 10/20 (code = '77038') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk 's avonds | ||
MBH identificatie | MBH_413_9 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_10_MA_1 | ||
Afspraakdatum | 3 sep 2018, om 09:35 | ||
gebruiksperiode | Vanaf 3 sep 2018, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | Gedurende 21 dagen 1 maal per dag 1 stuk | ||
Herhaalperiode cyclisch schema | 28 dagen | ||
MBH identificatie | MBH_413_10 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_11_MA_1 | ||
Afspraakdatum | 3 sep 2018, om 09:35 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 41 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | Fusidinezuur creme 20mg/g (code = '16705') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
Toedieningsweg | Cutaan (code = '7') | ||
Aanvullende instructie | Dun aanbrengen (code = '1033') | ||
Doseerinstructie 1 | Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
Doseerinstructie 2 | Dan gedurende 3 weken 1 maal per dag 2 gram | ||
Doseerinstructie 3 | Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
MBH identificatie | MBH_413_11 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_12_MA_1 | ||
Afspraakdatum | 3 sep 2018, om 11:25 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 3 weken | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | CODEINE TABLET 10MG (FOSFAAT) (code = '42773') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | Bij hoest 3 à 4 maal per uur 1 stuk | ||
MBH identificatie | MBH_413_12 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_13_MA_1 | ||
Afspraakdatum | 6 aug 2018, om 09:12 | ||
gebruiksperiode | Vanaf 6 aug 2018, gedurende 8 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 6 aug 2018, gedurende 8 dagen, 0.5 ml per uur parenteraal | ||
Toedieningsweg | Parenteraal (code = '10') | ||
Doseerinstructie | 0.5 ml per uur | ||
MBH identificatie | MBH_413_13 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_13_MA_2 | ||
Afspraakdatum | 14 aug 2018, om 11:25 | ||
gebruiksperiode | Vanaf 14 aug 2018, gedurende 8 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 14 aug 2018, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | ||
Toedieningsweg | Parenteraal (code = '10') | ||
Doseerinstructie | 0.2 à 0.5 ml per uur | ||
MBH identificatie | MBH_413_13 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_14_MA_1 | ||
Afspraakdatum | 3 sep 2018, om 11:25 | ||
gebruiksperiode | Tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520') | ||
Gebruiksinstructie | |||
Omschrijving | Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | ||
Toedieningsweg | Transdermaal (code = '58') | ||
Doseerinstructie | 1 maal per dag 1 stuk gedurende 16 uur | ||
MBH identificatie | MBH_413_14 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_15_MA_1 | ||
Afspraakdatum | 3 sep 2018, om 09:35 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 4 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
Geneesmiddel - Product specificatie | |||
Product naam | Haparine 100 ie= 10 ml | ||
Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
Farmaceutische vorm | Vloeistof (code = '434') | ||
Ingredient | |||
Ingredient code | Heparinum natricum (code = '898724') | ||
Sterkte | 100 internationale eenheid per 10 ml | ||
Ingredient | |||
Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | ||
Sterkte | 1 stuk per 10 ml | ||
Ingredient | |||
Ingredient code | NATRII CHLORIDUM (code = '256390') | ||
Sterkte | 0.09 gram per 10 ml | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | ||
Toedieningsweg | Parenteraal (code = '10') | ||
Doseerinstructie | 2 maal per dag 10 ml | ||
MBH identificatie | MBH_413_15 |
Verstrekkingsverzoeken XXX_Strengersz
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_15_VV_1 | ||
Datum | 3 sep 2018, om 09:35 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 100 ml | ||
Aantal herhalingen | 1 | ||
Geneesmiddel - Product specificatie | |||
Product naam | Haparine 100 ie= 10 ml | ||
Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
Farmaceutische vorm | Vloeistof (code = '434') | ||
Ingredient | |||
Ingredient code | Heparinum natricum (code = '898724') | ||
Sterkte | 100 internationale eenheid per 10 ml | ||
Ingredient | |||
Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | ||
Sterkte | 1 stuk per 10 ml | ||
Ingredient | |||
Ingredient code | NATRII CHLORIDUM (code = '256390') | ||
Sterkte | 0.09 gram per 10 ml | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Relatie naar medicatieafspraak | MBH_413_15_MA_1 | ||
MBH identificatie | MBH_413_15 |
Toedieningsafspraken XXX_Strengersz
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_1_TA_1 | ||
Afspraakdatum | 3 sep 2018, om 11:25 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 60 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_413_1_MA_1 | ||
MBH identificatie | MBH_413_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_2_TA_1 | ||
Afspraakdatum | 3 sep 2018, om 11:25 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 60 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
Toedieningsweg | Subcutaan (code = '21') | ||
Doseerinstructie | Exact iedere 3 uur 16 internationale eenheid | ||
Relatie naar medicatieafspraak | MBH_413_2_MA_1 | ||
MBH identificatie | MBH_413_2 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_3_TA_1 | ||
Afspraakdatum | 15 jul 2018, om 11:25 | ||
gebruiksperiode | Vanaf 15 jul 2018, gedurende 7 weken | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 3 maal per dag 1 à 2 stuks | ||
Relatie naar medicatieafspraak | MBH_413_3_MA_1 | ||
MBH identificatie | MBH_413_3 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_4_TA_1 | ||
Afspraakdatum | 14 aug 2018, om 10:26 | ||
gebruiksperiode | Vanaf 14 aug 2018, gedurende 30 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 14 aug 2018, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | ||
Toedieningsweg | Cutaan (code = '7') | ||
Aanvullende instructie | Aanbrengen (code = '1018') | ||
Doseerinstructie | 3 maal per dag | ||
Relatie naar medicatieafspraak | MBH_413_4_MA_1 | ||
MBH identificatie | MBH_413_4 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_5_TA_1 | ||
Afspraakdatum | 14 aug 2018, om 10:46 | ||
gebruiksperiode | Vanaf 14 aug 2018, gedurende 30 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | Ibuprofen PCH tablet 600mg (code = '641898') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 2 maal per dag 0.25 stuk | ||
Relatie naar medicatieafspraak | MBH_413_5_MA_1 | ||
MBH identificatie | MBH_413_5 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_6_TA_1 | ||
Afspraakdatum | 3 sep 2018, om 09:35 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 14 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | SOLUTIO HYDROGENII PEROXIDI 3% M/V (code = '603694') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
Toedieningsweg | Niet van toepassing (code = '1') | ||
Aanvullende instructie | Eerst oplossen in water (code = '27') | ||
Aanvullende instructie | Mond spoelen, daarna uitspugen (code = '69') | ||
Doseerinstructie | 2 maal per dag 10 à 15 ml | ||
Relatie naar medicatieafspraak | MBH_413_6_MA_1 | ||
MBH identificatie | MBH_413_6 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_7_TA_1 | ||
Afspraakdatum | 3 sep 2018, om 09:35 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 14 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE, subcutaan | ||
Toedieningsweg | Subcutaan (code = '21') | ||
Doseerinstructie | Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid | ||
Relatie naar medicatieafspraak | MBH_413_7_MA_1 | ||
MBH identificatie | MBH_413_7 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_8_TA_1 | ||
Afspraakdatum | 3 sep 2018, om 09:35 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 10 weken | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ALDARA CREME 50MG/G IN SACHET (code = '1198521') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | ||
Toedieningsweg | Subcutaan (code = '21') | ||
Aanvullende instructie | Voor de nacht (code = '1128') | ||
Aanvullende instructie | Aanbrengen (code = '1018') | ||
Doseerinstructie | Op maandag, woensdag en vrijdag | ||
Relatie naar medicatieafspraak | MBH_413_8_MA_1 | ||
MBH identificatie | MBH_413_8 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_9_TA_1 | ||
Afspraakdatum | 3 sep 2018, om 09:35 | ||
gebruiksperiode | Vanaf 3 sep 2018, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | INEGY TABLET 10/20MG (code = '1719785') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk 's avonds | ||
Relatie naar medicatieafspraak | MBH_413_9_MA_1 | ||
MBH identificatie | MBH_413_9 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_10_TA_1 | ||
Afspraakdatum | 3 sep 2018, om 09:35 | ||
gebruiksperiode | Vanaf 3 sep 2018, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | MARVELON TABLET (code = '416681') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | Gedurende 21 dagen 1 maal per dag 1 stuk | ||
Herhaalperiode cyclisch schema | 28 dagen | ||
Relatie naar medicatieafspraak | MBH_413_10_MA_1 | ||
MBH identificatie | MBH_413_10 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_11_TA_1 | ||
Afspraakdatum | 3 sep 2018, om 09:35 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 41 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | FUCIDIN CREME 20MG/G (code = '420956') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
Toedieningsweg | Cutaan (code = '7') | ||
Aanvullende instructie | Dun aanbrengen (code = '1033') | ||
Doseerinstructie 1 | Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
Doseerinstructie 2 | Dan gedurende 3 weken 1 maal per dag 2 gram | ||
Doseerinstructie 3 | Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
Relatie naar medicatieafspraak | MBH_413_11_MA_1 | ||
MBH identificatie | MBH_413_11 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_12_TA_1 | ||
Afspraakdatum | 3 sep 2018, om 11:25 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 3 weken | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | CODEINEFOSFAAT PCH TABLET 10MG (code = '874965') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | Bij hoest 3 à 4 maal per uur 1 stuk | ||
Relatie naar medicatieafspraak | MBH_413_12_MA_1 | ||
MBH identificatie | MBH_413_12 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_13_TA_1 | ||
Afspraakdatum | 6 aug 2018, om 09:12 | ||
gebruiksperiode | Vanaf 6 aug 2018, gedurende 8 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 6 aug 2018, gedurende 8 dagen, 0.5 ml per uur parenteraal | ||
Toedieningsweg | Parenteraal (code = '10') | ||
Doseerinstructie | 0.5 ml per uur | ||
Relatie naar medicatieafspraak | MBH_413_13_MA_1 | ||
MBH identificatie | MBH_413_13 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_13_TA_2 | ||
Afspraakdatum | 14 aug 2018, om 11:25 | ||
gebruiksperiode | Vanaf 14 aug 2018, gedurende 8 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 14 aug 2018, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | ||
Toedieningsweg | Parenteraal (code = '10') | ||
Doseerinstructie | 0.2 à 0.5 ml per uur | ||
Relatie naar medicatieafspraak | MBH_413_13_MA_2 | ||
MBH identificatie | MBH_413_13 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_14_TA_1 | ||
Afspraakdatum | 3 sep 2018, om 11:25 | ||
gebruiksperiode | Vanaf 16 aug 2018, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602') | ||
Gebruiksinstructie | |||
Omschrijving | Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | ||
Toedieningsweg | Transdermaal (code = '58') | ||
Doseerinstructie | 1 maal per dag 1 stuk gedurende 16 uur | ||
Relatie naar medicatieafspraak | MBH_413_14_MA_1 | ||
MBH identificatie | MBH_413_14 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_15_TA_1 | ||
Afspraakdatum | 3 sep 2018, om 09:35 | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 4 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel - Product specificatie | |||
Product naam | Haparine 100 ie= 10 ml | ||
Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
Farmaceutische vorm | Vloeistof (code = '434') | ||
Ingredient | |||
Ingredient code | Heparinum natricum (code = '898724') | ||
Sterkte | 100 internationale eenheid per 10 ml | ||
Ingredient | |||
Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | ||
Sterkte | 1 stuk per 10 ml | ||
Ingredient | |||
Ingredient code | NATRII CHLORIDUM (code = '256390') | ||
Sterkte | 0.09 gram per 10 ml | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | ||
Toedieningsweg | Parenteraal (code = '10') | ||
Doseerinstructie | 2 maal per dag 10 ml | ||
Relatie naar medicatieafspraak | MBH_413_15_MA_1 | ||
MBH identificatie | MBH_413_15 |
Verstrekkingen XXX_Strengersz
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_9_MVE_1 | ||
Datum | 3 sep 2018, om 10:35 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 90 stuks | ||
Geneesmiddel | INEGY TABLET 10/20MG (code = '1719785') | ||
Distributievorm | Geïndividualiseerd distributiesysteem (code = '1') | ||
MBH identificatie | MBH_413_9 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_15_MVE_1 | ||
Datum | 3 sep 2018, om 10:35 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 100 ml | ||
Geneesmiddel - Product specificatie | |||
Product naam | Haparine 100 ie= 10 ml | ||
Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
Farmaceutische vorm | Vloeistof (code = '434') | ||
Ingredient | |||
Ingredient code | Heparinum natricum (code = '898724') | ||
Sterkte | 100 internationale eenheid per 10 ml | ||
Ingredient | |||
Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | ||
Sterkte | 1 stuk per 10 ml | ||
Ingredient | |||
Ingredient code | NATRII CHLORIDUM (code = '256390') | ||
Sterkte | 0.09 gram per 10 ml | ||
Relatie naar verstrekkingsverzoek | MBH_513_15_VV_1 | ||
MBH identificatie | MBH_413_15 |
Medicatiegebruik XXX_Strengersz
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_1_MGB_1 | ||
Registratiedatum | 3 sep 2018, om 16:25 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 60 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
Gerelateerde afspraak: MA | MBH_413_1_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_1 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_2_MGB_1 | ||
Registratiedatum | 3 sep 2018, om 14:25 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 14 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 14 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
Toedieningsweg | Subcutaan (code = '21') | ||
Doseerinstructie | Exact iedere 3 uur 16 internationale eenheid | ||
Gerelateerde afspraak: MA | MBH_413_2_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_3_MGB_1 | ||
Registratiedatum | 3 sep 2018, om 10:45 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
gebruiksperiode | Vanaf 15 jul 2018, gedurende 7 weken | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 3 maal per dag 1 à 2 stuks | ||
Gerelateerde afspraak: MA | MBH_413_3_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_3 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_4_MGB_1 | ||
Registratiedatum | 19 aug 2018, om 13:44 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 14 aug 2018, tot en met 19 aug 2018 23:59 | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '92789') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 14 aug 2018 tot en met 19 aug 2018, 3 maal per dag aanbrengen, cutaan | ||
Toedieningsweg | Cutaan (code = '7') | ||
Aanvullende instructie | Aanbrengen (code = '1018') | ||
Doseerinstructie | 3 maal per dag | ||
Gerelateerde afspraak: MA | MBH_413_4_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_4 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_5_MGB_1 | ||
Registratiedatum | 3 sep 2018, om 12:38 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 14 aug 2018, gedurende 30 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Ibuprofen PCH tablet 600mg (code = '641898') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 2 maal per dag 0.25 stuk | ||
Gerelateerde afspraak: MA | MBH_413_5_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_5 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_6_MGB_1 | ||
Registratiedatum | 3 sep 2018, om 21:37 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 1 dag | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Waterstofperoxide 30MG/ML (code = '67016') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 1 dag, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
Toedieningsweg | Niet van toepassing (code = '1') | ||
Aanvullende instructie | Eerst oplossen in water (code = '27') | ||
Aanvullende instructie | Mond spoelen, daarna uitspugen (code = '69') | ||
Doseerinstructie | 2 maal per dag 10 à 15 ml | ||
Gerelateerde afspraak: MA | MBH_413_6_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_6 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_7_MGB_1 | ||
Registratiedatum | 3 sep 2018, om 14:05 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 3 sep 2018 14:00, tot en met 3 sep 2018 14:05 | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018 14:00 tot en met 3 sep 2018 14:05, om 14:00 16IE | ||
Toedieningsweg | Subcutaan (code = '21') | ||
Doseerinstructie | Elke dag om 16 internationale eenheid | ||
Gerelateerde afspraak: MA | MBH_413_7_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_7 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_7_MGB_2 | ||
Registratiedatum | 3 sep 2018, om 20:10 | ||
Gebruik indicator | True | ||
gebruiksperiode | Vanaf 3 sep 2018 20:00, tot en met 3 sep 2018 20:05 | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018 20:00 tot en met 3 sep 2018 20:05, om 20:00 16IE | ||
Toedieningsweg | Subcutaan (code = '21') | ||
Doseerinstructie | Elke dag om 16 internationale eenheid | ||
Gerelateerde afspraak: MA | MBH_413_7_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_7 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_8_MGB_1 | ||
Registratiedatum | 3 sep 2018, om 23:59 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 10 weken | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | IMIQUIMOD 50MG/G CREME (code = '55050') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen | ||
Aanvullende instructie | Voor de nacht (code = '1128') | ||
Aanvullende instructie | Aanbrengen (code = '1018') | ||
Doseerinstructie | Op maandag, woensdag en vrijdag | ||
Gerelateerde afspraak: MA | MBH_413_8_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_8 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_9_MGB_1 | ||
Registratiedatum | 3 sep 2018, om 22:35 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
gebruiksperiode | Vanaf 3 sep 2018, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | EZETIMIB/SIMVASTATINE 10/20 (code = '77038') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, tot nader order, 1 maal daags ’s avonds innemen | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | 1 maal per dag 1 stuk 's avonds | ||
Gerelateerde afspraak: MA | MBH_413_9_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_9 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_10_MGB_1 | ||
Registratiedatum | 3 sep 2018, om 09:35 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
gebruiksperiode | Vanaf 3 sep 2018, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||
Doseerinstructie | Gedurende 21 dagen 1 maal per dag 1 stuk | ||
Herhaalperiode cyclisch schema | 28 dagen | ||
Gerelateerde afspraak: MA | MBH_413_10_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_10 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_11_MGB_1 | ||
Registratiedatum | 3 sep 2018, om 15:35 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 41 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Fusidinezuur creme 20mg/g (code = '16705') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
Aanvullende instructie | Dun aanbrengen (code = '1033') | ||
Doseerinstructie 1 | Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
Doseerinstructie | Dan gedurende 3 weken 1 maal per dag 2 gram | ||
Doseerinstructie | Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
Gerelateerde afspraak: MA | MBH_413_11_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_11 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_12_MGB_1 | ||
Registratiedatum | 3 sep 2018, om 22:35 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 3 weken | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | CODEINE TABLET 10MG (FOSFAAT) (code = '42773') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
Toedieningsweg | Oraal (code = '9') | ||
Doseerinstructie | Bij hoest 3 à 4 maal per uur 1 stuk | ||
Gerelateerde afspraak: MA | MBH_413_12_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_12 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_14_MGB_1 | ||
Registratiedatum | 3 sep 2018, om 22:35 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
gebruiksperiode | Tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister). | ||
Toedieningsweg | Transdermaal (code = '58') | ||
Doseerinstructie | 1 maal per dag 1 stuk gedurende 16 uur | ||
Gerelateerde afspraak: MA | MBH_413_14_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_14 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_15_MGB_1 | ||
Registratiedatum | 3 sep 2018, om 10:35 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
gebruiksperiode | Vanaf 3 sep 2018, gedurende 4 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel - Product specificatie | |||
Product naam | Haparine 100 ie= 10 ml | ||
Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
Farmaceutische vorm | Vloeistof (code = '434') | ||
Ingredient | |||
Ingredient code | Heparinum natricum (code = '898724') | ||
Sterkte | 100 internationale eenheid per 10 ml | ||
Ingredient | |||
Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | ||
Sterkte | 1 stuk per 10 ml | ||
Ingredient | |||
Ingredient code | NATRII CHLORIDUM (code = '256390') | ||
Sterkte | 0.09 gram per 10 ml | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml | ||
Toedieningsweg | Parenteraal (code = '10') | ||
Doseerinstructie | 2 maal per dag 10 ml | ||
Gerelateerde afspraak: MA | MBH_413_15_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_15 |